procarbazine has been researched along with lomustine in 434 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 157 (36.18) | 18.7374 |
| 1990's | 98 (22.58) | 18.2507 |
| 2000's | 100 (23.04) | 29.6817 |
| 2010's | 68 (15.67) | 24.3611 |
| 2020's | 11 (2.53) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, VA | 2 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gaeta, JF; Mirand, EA; Murphy, GP; Varkarakis, MJ | 1 |
| Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S | 1 |
| Bruntsch, U | 1 |
| Das, S; Freedman, LS; Garrett, MJ; Smith, JD | 1 |
| Dold, U | 1 |
| Golbey, RB | 1 |
| Portlock, CS; Porzig, KJ; Robertson, A; Rosenberg, SA | 1 |
| Bitran, JD; Cooksey, JA; DeMeester, TR; Desser, RK; Golomb, HM; Mintz, U | 1 |
| Greiner, RH; Markwalder, H; Seiler, RW; Zimmerman, A | 1 |
| Blom, J; Heim, WJ; Miller, CF; Weltz, MD | 1 |
| Eriksson, G; Lambert, B | 1 |
| Boston, B | 1 |
| Boldrey, EB; Drafts, D; Enot, KJ; Gutin, P; Levin, VA; Wilson, CB | 1 |
| Carr, DT; Hansen, HH; Sealy, R; Selawry, OS; Simon, R; Tucker, RD; van Wyk, CE | 1 |
| Alexander, M; Daniels, JR; Glatstein, EJ; Williams, C | 1 |
| Boesel, C; Ertel, IJ | 1 |
| Heiss, WD; Mamoli, B; Turnheim, M | 1 |
| Bunn, PA; Chretien, PB; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston, AV; Kenady, DE; Lipson, SD; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE | 1 |
| Bunn, PA; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston-Early, A; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE | 1 |
| Buge, A; Poisson, M; Pouillart, P | 1 |
| Besuschio, S; Bezares, R; Calabria, SI; de Bonesana, AC; de Sica, SC; Garay, GE; Lein, JM; Macchi, A; Magnasco, J; Morgenfeld, M; Pavlovsky, S; Pileggi, J; Somoza, N; Suárez, A | 1 |
| Hasegawa, H; Posner, JB; Shapiro, WR | 1 |
| Crafts, DC; Levin, VA; Townsend, J; Wilson, CB | 1 |
| Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL | 1 |
| Crafts, DC; Edwards, MS; Levin, VA; Pischer, TL; Wilson, CB | 1 |
| Levin, VA; Wilson, CB | 3 |
| Buge, A; Gautier, H; Huguenin, P; Morin, P; Palangie, T; Poisson, M; Pouillart, P | 1 |
| Bartolucci, A; Dorfman, RF; Durant, JR; Gams, RA; Velez-Garcia, E | 1 |
| Diggs, CH; Kvols, LK; Levi, JA; Wiernik, PH | 1 |
| Shapiro, WR; Young, DF | 1 |
| Boldrey, EB; Enot, KJ; Gutin, PH; Kumar, AR; Levin, V; Powell, M; Wilson, CB | 1 |
| Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U | 2 |
| Boiardi, A; Broggi, G; Fariselli, L; Milanesi, I; Silvani, A | 1 |
| Djuric, LJ; Jeremic, B; Jevremovic, S; Jovanovic, D; Mijatovic, LJ | 1 |
| Gutin, PH; Larson, DA; Phillips, TL; Prados, MD; Sneed, PK; Wara, WM; Weaver, KA | 1 |
| Filip, A; Gabryś, K; Kotlarek-Haus, S; Kuliszkiewicz-Janus, M; Wołowiec, D | 1 |
| Boratyński, W | 1 |
| Broder, LE; Charyulu, KN; Lenz, C; Rao, RK; Saldana, MJ; Selawry, OS; Sridhar, KS | 1 |
| Chamberlain, MC; Levin, VA | 2 |
| Sutcliffe, SB | 1 |
| Costa, A; Fernández, I; Garcia, I; Magnasco, H; Montero, C; Muriel, FS; Pavlovsky, S; Sanahuja, FL; Santarelli, MT; Schwartz, L | 1 |
| Glass, J; Gruber, ML; Hochberg, FH; Louis, DN; Rattner, B; Smith, D | 1 |
| DeVita, VT; Longo, DL | 1 |
| Cairncross, JG; Macdonald, DR; Ramsay, DA | 1 |
| Gutin, PH; Larson, DA; Leibel, SA; Levin, VA; Phillips, TL; Prados, MD; Silver, P; Sneed, PK; Wara, WM; Weaver, KA | 1 |
| Ahn, DK; Davis, RL; Flam, MS; Gutin, PH; Levin, VA; Phillips, TL; Prados, MD; Wara, WM; Wilson, CB | 1 |
| Bellmunt, J; Bodi, R; Jolis, L; Mur, E; Navarro, M; Rubio, D; Solé, LA | 1 |
| Bailey, NM; Hagemeister, FB; Liang, JC; Sen, P | 1 |
| Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J | 1 |
| Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG | 1 |
| Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S | 1 |
| al-Idrissi, HY; Ibrahim, EM | 1 |
| Bastian, AW; DeVita, VT; Duffey, PL; Hubbard, SM; Jaffe, ES; Longo, DL; Phares, JC; Wiernik, PH; Young, RC | 1 |
| Chan, TK; Chiu, E; Liang, R; Loke, SL; Todd, D | 1 |
| Glover, DJ | 1 |
| Bohunický, L; Fuchsberger, P; Gyárfás, J; Koza, I; Mardiak, J; Mociková, K; Spánik, S; Sufliarsky, J; Svancárová, L; Thalmeinerová, Z | 1 |
| Demina, EA; Kondrat'eva, NF; Pirogova, NA | 1 |
| Afanasova, NV; Baĭsogolov, GD; Shakhtarina, SV | 2 |
| Gattamaneni, HR; Ogilvy-Stuart, AL; Shalet, SM | 1 |
| Cairncross, JG; Macdonald, DR | 2 |
| Anderson, H; Borgström, S; Brun, A; Cronqvist, S; Hougaard, K; Malmström, P; Salford, LG; Sandberg-Wollheim, M; Strömblad, LG | 1 |
| Davis, RL; Gutin, PH; Hannigan, J; Levin, VA; Silver, P; Wara, WM; Wilson, CB | 1 |
| Cellerino, R; Dazzi, C; Guidi, F; Isidori, P; Rossi, A; Torresi, U; Tummarello, D | 1 |
| Bradford, R; Darling, JL; Sier, N; Thomas, DG | 1 |
| Bradford, R; Darling, JL; Thomas, DG | 1 |
| Cairncross, JG; Gaspar, LE; Macdonald, DR | 1 |
| Wright, JC | 1 |
| Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S | 2 |
| Kholin, AV | 1 |
| Bonadonna, G; Santoro, A; Valagussa, P | 1 |
| Anderson, JR; Coleman, M; Frizzera, G; Gottlieb, A; Holland, JF; Nissen, NI; Pajak, TF; Propert, KJ; Stutzman, L; Vinciguerra, V | 1 |
| Gabryś, K; Kotlarek-Haus, S; Sciborski, R | 2 |
| Cao, YF; Chen, YR; Fang, MS; Huang, OL; Liao, ML; Wu, SC; Wu, SF; Wu, SZ; Xu, CW; Yang, XF | 1 |
| Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K | 1 |
| Koziner, B; Zori Comba, A | 1 |
| Anger, G; Herold, M; Höche, D; Kästner, R | 1 |
| Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD | 1 |
| Schiffer, CA; Wiernik, PH | 1 |
| Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G | 1 |
| Bladé, J; Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C | 1 |
| Straus, DJ | 1 |
| Anger, G; Herold, M; Höche, D; Kästner, R; Keinert, K; Wutke, K | 1 |
| Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ | 1 |
| Dallüge, KH; Grunau, H; Hüttner, J; Merkle, K; Quadt, C; Tanneberger, S; Wiener, N | 1 |
| Boesel, CP; Ertel, IJ; Evans, AE; Hammond, D; Jenkin, RD; Ortega, JA; Sposto, R; Venes, JL; Wara, W | 1 |
| Wang, QL | 1 |
| Goldobenko, GV; Makhomova, LA; Poliakov, VE; Susuleva, NA; Tsygankin, VI | 1 |
| Clayton, PE; Jones, PH; Price, DA; Shalet, SM | 1 |
| Bonichon, F; Chauvergne, J; de Mascarel, I; Eghbali, H; Hoerni, B; Lagarde, P | 2 |
| Gubareva, AA; Kindzel'skiĭ, LP | 1 |
| Coleman, RE; Djang, WT; Falletta, JM; Friedman, HS; Halperin, EC; Kurtzberg, J; Longee, DC; Oakes, WJ; Schold, SC | 1 |
| Cellerino, R; Guidi, F; Isidori, P; Porfiri, E; Raspugli, M; Tummarello, D | 1 |
| Bunn, PA; Carney, DN; Cohen, MH; Glatstein, E; Ihde, DC; Johnston-Early, A; Lichter, AS; Makuch, RW; Minna, JD | 1 |
| Tanneberger, S | 1 |
| Davis, RL; Gutin, PH; Levin, VA; Nutik, S; Resser, KJ; Vestnys, P; Wara, WM; Wilson, CB; Yatsko, K | 1 |
| Bodurtha, A; Iscoe, N; Paterson, A; Quirt, I; Russell, J; Shelley, W; Young, V | 1 |
| Bychkov, MB | 1 |
| Brooks, BJ; Bunn, PA; Cohen, MH; Edison, M; Johnston-Early, A; Lichter, AS; Makuch, RW; Seifter, EJ; Walsh, TE; Zabell, A | 1 |
| Livingston, RB | 1 |
| Chak, LY; Cox, RS; Kushlan, PD; Porzig, KJ; Sikic, BI; Wasserstein, P; Zatz, LM | 1 |
| Abrams, RA; Bunn, PA; Carney, DN; Cohen, MH; Deisseroth, AB; Ihde, DC; Johnston-Early, A; Lichter, AS; Makuch, RW; Veach, SR | 1 |
| Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT | 1 |
| Andres, DF; Catanese, J; Dorfman, HD; Dutcher, JP; Wiernik, PH | 1 |
| Kobayashi, T | 1 |
| Corrado, C; Garcia, I; Magnasco, O; Maschio, M; Montero, C; Muriel, FS; Pavlovsky, S; Sanahuja, FL; Santarelli, MT; Schwartz, L | 1 |
| Brämswig, JH; Schellong, G; Schwarze, EW; Wannenmacher, M | 1 |
| Arkhipov, AI; Gershanovich, ML; Vilenskiĭ, BS | 1 |
| Albers, GW; Forno, LS; Hoyt, WF; Shratter, LA | 1 |
| Astapov, BM; Shakhtarina, SV | 1 |
| Brunat-Mentigny, M; Chastagner, P; Czorny, A; Lapras, C; Olive, D; Philip, T; Zucker, JM | 1 |
| Buxó Costa, J; Galofré, M; Pardo Peret, P; Pedro Olivé, C; Rodríguez Ferrera, JC; Rodríguez Méndez, F; Sans-Sabrafen, J; Woessner, S | 1 |
| Baysogolov, GD; Shakhtarina, SV | 1 |
| Carmo-Pereira, J; Costa, FO; Henriques, E | 2 |
| Chojnowski, K; Dmochowska, M; Krykowski, E; Olszańska-Skorek, T; Robak, T; Urbańska-Ryś, H | 1 |
| Afra, D; Eckhardt, S; Kerpel-Fronius, S; Kocsis, B | 1 |
| Ardizzoni, A; Grimaldi, A; Repetto, L; Rosso, R; Sertoli, MR | 1 |
| Baumgartner, G; Baumgartner, M | 1 |
| Poliakov, VE; Tsygankin, VI | 1 |
| Aliev, BM; Blokhina, NG; Kaverzneva, MM; Kruglova, GV; Vasygova, NF | 1 |
| Andrieu, JM; Cramer, P | 1 |
| Bozek, T; Capra, LG; Collins, CD; Darling, JL; Godlee, JN; Mooney, C; Mott, TJ; Paul, EA; Thomas, DG; Tobias, JS | 1 |
| Darling, JL | 1 |
| Eltringham, JR; Eyre, HJ; Frank, J; McDonald, B; O'Bryan, RM; Quagliana, JM; Rivkin, SE | 1 |
| Hodson, DI; Levitt, M; Malaker, K; Meikle, AL | 1 |
| Bohnen, R; Carter, SK; Chak, LY; Daniels, JR; Gandara, D; Kohler, M; Lockbaum, P; Reynolds, R; Sikic, BI; Yu, J | 1 |
| Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC | 1 |
| Economopoulos, T; Malpas, JS; Stansfeld, AG; Sutcliffe, SB; Wrigley, PF | 1 |
| Seiler, RW | 1 |
| Bloomfield, CD; Coleman, M; Glicksman, AS; Glidewell, OJ; Gottlieb, AJ; Holland, JF; Nissen, NI; Pajak, TF; Rafla, S; Stutzman, L; Vinciguerra, V | 1 |
| Bonadonna, G | 1 |
| Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD | 1 |
| Diehl, V; Peters, HD; Schmoll, HJ; von Roemeling, R; Weiss, J | 1 |
| Clarkson, BD; Koziner, B; Lee, BJ; Myers, J; Straus, DJ | 1 |
| Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ | 1 |
| Cabanillas, F; Hagemeister, F; Tannir, N; Velasquez, W | 1 |
| Harker, WG; Kushlan, P; Rosenberg, SA | 1 |
| deKernion, JB; Lindner, A | 1 |
| Bagwell, S; Broder, LE; Charyulu, KN; Ng, A; Selawry, OS | 1 |
| Baker, MA; Brown, TC; Curtis, JE; Deboer, G; Evans, WK; Feld, R; Keen, CW; Pringle, JF; Quirt, IC; Yeoh, JL | 1 |
| Aisner, J; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
| Alberto, P; Barrelet, L; Berchtold, W; Jungi, F; Martz, G; Obrecht, P; Sonntag, R | 1 |
| Aisner, J; Poplin, EA; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
| Jones, JM; Peckham, MJ; Shorthouse, AJ; Steel, GG | 1 |
| Krawczyk, K; Krochmal, M; Kulpa, J; Pawlicki, M | 1 |
| Antic, R; Drew, MJ; Gill, PG; McLennan, G; Robinson, PC | 1 |
| Danil'ian, VM; Linchenko, IF | 1 |
| Ausekar, BV; Bychkov, MB; Perevodchikova, NI | 1 |
| Briancon, S; Feintrenie, X; Lamaze, R; Lamy, P; Thisse, JY; Watrin, H | 1 |
| de Vries, EG; Halie, MR; Mulder, NH; Postmus, PE; van Luyn, M | 1 |
| Gregor, A; Smyth, JF | 1 |
| Bateman, JR; Hum, GJ; Liebman, HA; Ryden, VM; Sheehan, WW | 1 |
| Bloomfield, C; Cooper, MR; Glicksman, AS; Gottlieb, AJ; Holland, JF; Nissen, N; Pajak, TF; Richards, F | 1 |
| Boiron, M; d'Agay, MF; Ferme, C; Gisselbrecht, C; Marty, M; Teillet, F | 1 |
| Biran, S; Brufman, G; Catane, R; Halpern, J; Sulkes, A | 1 |
| Baĭsogolov, GD; Shakhtarina, SV | 1 |
| Ankudinov, VA; Makhonova, LA; Poliakov, VE; Tsygankin, VI | 1 |
| Hanak, H; Heinz, R | 1 |
| Sviridova, AV; Tsyplenkov, VG | 1 |
| Shishkin, IP | 1 |
| Flament, H; Grisold, W; Jellinger, K; Volc, D; Vollmer, R; Weiss, R | 1 |
| Fuller, LM; Hagemeister, FB | 1 |
| Bierling, P; Brun, B; Dreyfus, B; Farcet, JP; Imbert, M; Kuentz, M; Le Bezu, M; Lebourgeois, JP; Reyes, F; Rochant, H; Vernant, JP | 1 |
| Barros, CA; Besuschio, SC; Cavagnaro, F; Garay, G; Magnasco, J; Morgenfeld, M; Palau, M; Pavlovsky, S; Sackmann Muriel, F; Saslavsky, J; Somoza, N; Suárez, A | 1 |
| Koshel', IV; Tsyplenkov, VG; Vialushkin, BIa | 1 |
| Andrieu, JM; Casassus, P; Coscas, Y; Darmont, J; Goubeau, C; Jacquillat, C; Katz, M; Tricot, G; Weil, M | 1 |
| Aiba, K; Dohmyo, M; Ezaki, K; Horikoshi, N; Inagaki, J; Inoue, K; Kobayashi, T; Kuraishi, Y; Miyamoto, H; Nagata, T; Ogawa, M | 1 |
| Cohen, M; Mehta, CR; Mountain, CF; Tucker, RD; Vincent, RG; Vogel, C; Wilson, HE | 1 |
| Bonesana, AC; Kvicala, R; Morgenfeld, M; Ojeda, F; Papendieck, C; Pavlovsky, S; Penchansky, L; Sackmann-Muriel, F; Schwartz, L; Sica, M | 1 |
| Levin, VA; Vestnys, PS; Wilson, CB | 1 |
| Hildebrand, J | 1 |
| Butti, G; Knerich, R; Pezzotta, S | 1 |
| Alfonso, L; Barroso, MC; Bello, JL; Betancourt, M; Kariev, NI; Lage, A; Mainardi, JV | 1 |
| Fodstad, O; Olsnes, S; Pihl, A; Tveit, KM | 1 |
| Flament, H; Grisold, W; Jellinger, K; Podreka, I; Volc, D; Vollmer, R; Weiss, R | 1 |
| Graf, W; Stäubli, M; Straub, PW | 1 |
| Berchtold, W; Bernasconi, S; Feldges, A; Imbach, P; Lüthi, A; Plüss, HJ; Seiler, RW; Vassella, F; Wagner, HP; Wyss, M | 1 |
| Fodstad, O; Pihl, A; Tveit, KM | 1 |
| Aass, N; Fodstad, O; Pihl, A | 2 |
| Dillman, RO; Green, MR; Horton, C | 1 |
| Carmo-Pereira, J; Costa, FO; Henriques, E; Pimentel, P | 1 |
| Bank, A; Blom, J; Brunner, K; Cooper, MR; Cuttner, J; Falkson, G; Glidewell, OJ; Gottlieb, AJ; Grunwald, H; Haurani, F; Holland, JF; Leone, L; Nissen, NI; Pajak, TF; Seligman, BR; Silver, RT; Spurr, CL; Stutzman, L; Weiss, RB | 1 |
| Gabryś, K; Kotlarek-Haus, S; Potoczek, S | 1 |
| Barrantes, JC; Barrantes, M; García, I; González, M; Jiménez, R; Lobo-Sanahuja, F | 1 |
| Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F | 1 |
| Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G | 1 |
| Postmus, PE; Smit, EF | 1 |
| Cairncross, JG; Eisenhauer, EA | 1 |
| Bruner, J; Kyritsis, AP; Leeds, N; Levin, VA; Maor, MH; Rodriguez, L; Sawaya, R; Thall, PF; Woo, S; Yung, WK | 1 |
| Coleman, CN; Loeffler, JS; Shrieve, DC | 1 |
| Avanzini, P; Cavanna, L; Di Renzo, N; Federico, M; Gobbi, PG; Grignani, G; Iannitto, E; Narni, F; Partesotti, G; Pieresca, C | 1 |
| Carson, C; Dorigo, O; Fakhrai, H; Gjerset, R; Khaleghi, T; Koziol, J; Royston, I; Shawler, D; Shiftan, TA; Sobol, RE | 1 |
| Davis, RL; Gutin, PH; Lamborn, K; Levin, VA; Phillips, TL; Prados, MR; Wara, WM; Wilson, CB | 1 |
| Evans, BD; Harvey, VJ; Mak, D; Melville, P; Mitchell, PL; Samuel, LM; Thompson, PI | 1 |
| Cole, SJ; Fraser, DE; Whittle, IR | 1 |
| Fine, HA | 1 |
| Buckner, J; Cairncross, G; Cascino, T; Dropcho, E; Fulton, D; Lee, D; Ludwin, S; Macdonald, D; Schold, C; Stewart, D | 1 |
| Broder, LE; Charyulu, KN; Donnelly, EJ; Rao, RK; Raub, WA; Saldana, MJ; Selawry, OS; Sridhar, KS | 1 |
| Cairncross, JG | 1 |
| Fairey, AF; Jones, HW; Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
| Chamberlain, MC | 2 |
| Elis, A; Lishner, M; Ravid, M; Savin, H | 1 |
| Habrand, JL; Kalifa, C; Lemerle, J; Pierga, JY; Terrier-Lacombe, MJ | 1 |
| Blanchard, CG; Eastman, AY; McSharry, JJ; Pearce, T; Portuese, E; Powell, D; Remick, SC; Wagner, H; Wighton, T; Wolf, BC | 1 |
| Bates, T; Baum, M; Dobbs, HJ; Ebbs, SR; Fallowfield, LJ; Fraser, SC | 1 |
| Beck, JD; Buchfelder, M; Erhardt, J; Fietkau, R; Grabenbauer, GG; Löhnert, C; Neubauer, U; Reitz, S; Seyer, H; Thierauf, P | 1 |
| DeAngelis, LM; Krol, GS; Mason, WP | 1 |
| Ilveskoski, I; Lanning, M; Mäkipernaa, A; Perkkiö, M; Pihko, H; Saarinen, UM; Salmi, TT; Wiklund, T | 1 |
| Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H | 1 |
| Stewart, A | 1 |
| Darling, JL; Haselsberger, K; Peterson, DC; Thomas, DG | 1 |
| Finkelstein, D; Harsh, GR; Hochberg, FH; Kim, L; Louis, DN; Patel, H; Thornton, AF | 1 |
| Bruner, J; Flowers, A; Gleason, MJ; Ictech, SE; Jaeckle, KA; Kyritsis, AP; Levin, VA; Yung, WK | 1 |
| Andrieu, JM; Briere, J; Casassus, P; Desablens, B; Hunault, M; Ifrah, N; Jais, JP; Le Maignan, C; Moreau, P | 1 |
| Davis, RL; Edwards, MS; Lamborn, K; Levin, VA; Prados, MD; Rabbitt, J | 1 |
| Dakhil, S; Hess, K; Jaeckle, KA; Kaba, SE; Kyritsis, AP; Levin, VA; Mercier, R; Yung, WK | 1 |
| Allison, RR; Barry, T; Schulsinger, A; Shin, KH; Vongtama, V | 1 |
| Alderete, D; Alfaro, E; Casak, S; Chantada, G; Felice, MS; Gallo, G; Quinteros, R; Sackmann-Muriel, F; Scopinaro, M; Zubizarreta, P | 1 |
| Janković, S; Marković, M; Petrović, M; Radosević, N; Ugljesić, M | 1 |
| Chamberlain, MC; Kormanik, PA | 1 |
| Bouffet, E; Bret, P; Helfre, S; Jouvet, A; Mertens, P; Mornex, F; Sindou, M; Thiesse, P | 1 |
| Heimans, JJ; Kralendonk, JH; Postma, TJ; van Groeningen, CJ; Weerts, JG; Witjes, RJ | 1 |
| Bauman, GS; Cairncross, JG; Fisher, BJ; Macdonald, D | 1 |
| Abele, M; Dichgans, J; Leonhardt, M; Weller, M | 1 |
| Bianco, AR; Biondi, E; Lauria, R; Matano, E; Montesarchio, V; Morabito, A; Pagliarulo, C; Palmieri, G; Rea, A; Tagliaferri, P | 1 |
| Anderson, JR; Brunner, K; Coleman, M; Glicksman, A; Gottlieb, A; Holland, JF; Kaufman, T; Nissen, N; Peterson, B; Propert, KJ; Rafla, S | 1 |
| Boogerd, W; Heimans, JJ; Kros, JM; Krouwer, HG; Pronk, LC; Punt, CJ; Taphoorn, MJ; Tijssen, CC; Twijnstra, A; van den Bent, MJ; van Groeningen, CJ; Zonnenberg, BA | 1 |
| Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M | 1 |
| Cornetta, K; Dropcho, E; Heilman, DK; Jakacki, RI; Jamison, C; Macdonald, DR; Mathews, VP; Williams, DA | 1 |
| Brown, MT; Gockerman, JP; Perry, JR | 1 |
| Shimoyama, M; Tsushita, K; Utsumi, M | 1 |
| Gundersen, S; Lote, K; Watne, K | 1 |
| Bruner, JM; Groves, MD; Hess, K; Jaeckle, KA; Kyritsis, AP; Levin, VA; Maor, MH; Meyers, C; Peterson, P; Sawaya, RE; Yung, WK | 1 |
| Cairncross, JG; Macdonald, DR; Paleologos, NA; Vick, NA | 1 |
| Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
| Aleksandrovic, J; Dagovic, A; Gruijicic, D; Jeremic, B; Milicic, B; Nikolic, N; Shibamoto, Y; Stojanovic, M | 1 |
| Curran, WJ; Kramer, S; Leibel, S; Nelson, DF; Prados, MD; Scott, C | 1 |
| Allen, JC; Jakacki, RI; Jamison, C; Siffert, J; Velasquez, L | 1 |
| Yung, WK | 1 |
| Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, H; Schultz, C; Scott, C; Urtasun, R | 1 |
| Joensuu, H; Kivistö, KT; Mäenpää, H; Neuvonen, PJ; Villikka, K | 1 |
| Henson, JW; Louis, DN; Thornton, AF | 1 |
| Bamberg, M; Brugger, W; Dichgans, J; Herrlinger, U; Küker, W; Weller, M | 1 |
| Andersson, AM; Geijer, B; Holtås, S; Källén, K; Malmström, P; Rosén, I; Ryding, E | 1 |
| Bamberg, M; Dichgans, J; Grote, EH; Meyermann, R; Schabet, M; Streffer, J; Voigt, K; Weller, M | 1 |
| Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP | 1 |
| Boiardi, A; Broggi, G; Eoli, M; Pozzi, A; Salmaggi, A; Silvani, A | 1 |
| Darling, JL; Harding, B; Harkness, W; Hayward, R; Lewandowicz, GM; Thomas, DG | 1 |
| Bruner, JM; Chang, SM; Choucair, A; Flynn, PJ; Gleason, MJ; Hess, KR; Jaeckle, KA; Kyritsis, AP; Levin, VA; Prados, MD; Uhm, JH | 1 |
| Groeneveld, GJ; Heimans, JJ; Kappelle, AC; Postma, TJ; Sneeuw, KC; Taphoorn, MJ; van den Bent, MJ; van Groeningen, CJ; Zonnenberg, BA | 1 |
| Eich, HT; Eich, PD; Micke, O; Müller, R; Staar, S; Stützer, H | 1 |
| Blanchard, CG; Dezube, BJ; Haase, RF; Mastrianni, DM; Nazeer, T; Ramnes, CR; Remick, SC; Sedransk, N | 1 |
| Lesser, GJ | 1 |
| Bauman, GS; Cairncross, JG | 1 |
| Davis, R; Edwards, M; Lamborn, K; Levin, VA; Malec, M; Prados, MD; Rabbitt, J; Wara, W | 1 |
| Bayer, R; Cairncross, G; Forsyth, P; Hu, W; Kaminer, L; Macdonald, D; Paleologos, N; Peterson, K; Ramsay, D; Rosenfeld, S; Salzman, D; Smith, A; Stewart, D; Swinnen, L | 1 |
| Boiardi, A | 1 |
| Bennett, JM; Glick, JH; Habermann, TM; Leong, T; Neiman, RS; Oken, MM; Schuster, S; Wiernik, PH | 1 |
| Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C | 1 |
| Chinot, O | 1 |
| Chamberlain, MC; Jaeckle, KA | 1 |
| Diabira, S; Gamelin, E; Jadaud, E; Menei, P; Rousselet, MC; Soulier, P | 1 |
| Bruner, J; Chang, E; Gleason, MJ; Hess, KR; Ictech, SA; Kyritsis, A; Leeds, N; Levin, VA; Maor, MH; Meyers, CA; Yung, WK | 1 |
| Gal, O; Kovner, F; Ron, IG; Vishne, TH | 1 |
| Kochi, M; Ushio, Y | 1 |
| Croteau, D; Mikkelsen, T | 1 |
| Knowling, M; Murphy, C; Pickles, T; Thiesse, B | 1 |
| Klockgether, T; Ko, YD; Kraus, JA; Nettekoven, W; Pels, H; Schlegel, U; Vetter, H; Zander, T | 1 |
| Baker, MJ; Brem, S; Daniels, S; Phuphanich, S; Sherman, B | 1 |
| Barista, I; Cabanillas, F; Chronowski, GM; Cox, JD; Ha, CS; Hagemeister, FB; Hess, MA; Sarris, AH; Tucker, SL; Wilder, RB | 1 |
| Brown, PD; Buckner, JC; Erickson, BJ; Gesme, D; Hammack, JE; Hawkins, R; Jenkins, R; Levitt, R; O'Fallon, JR; Scheithauer, BW; Shaw, EG; Stafford, S | 1 |
| Delattre, JY; Keime-Guibert, F; Louis, E; Sanson, M | 1 |
| Basso, U; Berti, F; Brandes, AA; Ermani, M; Gardiman, M; Monfardini, S; Pinna, G; Rotilio, A; Scienza, R; Vastola, F | 1 |
| Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
| Dinjens, W; Graveland, W; Jenkins, RB; Kros, JM; Langenberg, K; Looijenga, LH; Sillevis Smitt, PA; Uytdewilligen, L; van den Bent, MJ | 1 |
| Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ | 1 |
| Baron, B; Boogerd, W; Bravo Marques, J; Chinot, O; De Beule, N; Kros, JM; Taphoorn, MJ; van den Bent, MJ; van der Rijt, CC; Vecht, CJ | 1 |
| Bret, P; Carrie, C; Frappaz, D; Ginestet, G; Guyotat, J; Jouanneau, E; Jouvet, A; Martel Lafay, I; Pommier, P; Sindou, M; Sunyach, MP | 1 |
| Bellei, M; Brice, P; Brugiatelli, M; Carella, AM; Colombat, P; Di Renzo, N; Fabbiano, F; Federico, M; Gisselbrecht, C; Goldstone, A; Luminari, S; Moretti, L; Nagler, A | 1 |
| Baron, B; Bogdhan, U; Chinot, O; De Beule, N; Delattre, JY; Frenay, M; Hildebrand, J; Hoang-Xuan, K; Soubeyran, P; Taillandier, L | 1 |
| Hoddes, JA; Lancaster, DL; Michalski, A | 1 |
| Schiff, D | 2 |
| Engelhard, HH; Mundt, A; Stelea, A | 1 |
| Austin, RC; Ellis, TL; Stieber, VW | 1 |
| Khachatrian, VA; Khil'ko, VA; Shuleshova, NV | 1 |
| Berger, MS; Chang, SM; Schmidt, MH; Uyehara-Lock, JH; von Koch, CS | 1 |
| Bachert, P; Debus, J; Henze, M; Lichy, CM; Lichy, MP; Schlemmer, HP | 1 |
| Abrey, LE; Bayer, R; Cairncross, JG; Childs, BH; DeAngelis, LM; Finlay, JL; Forsyth, P; Gardner, S; Hu, W; Kaminer, L; Macdonald, DR; Nimer, SD; Paleologos, N; Peterson, K; Ramsey, DA; Rosenfeld, S; Salzman, D; Smith, AM; Stewart, D; Swinnen, L; Weaver, S | 1 |
| Borgognone, M; Costanza, A; Laguzzi, E; Mutani, R; Nobile, M; Rudà, R; Soffietti, R | 1 |
| Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, HM; Schultz, C; Seiferheld, W; Urtasun, R | 1 |
| Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F | 1 |
| Alchaar, H; Bleuse, A; Bondiau, PY; Bourg, V; Brunetto, JL; Chanalet, S; Chatel, M; Courdi, A; Darcourt, J; Fauchon, F; Fontaine, D; Frénay, M; Grellier, P; Guibert, F; Lanteri-Minet, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Paquis, V; Ramaioli, A; Rasendrarijao, D; Vandenbos, F | 1 |
| Carpentier, A; Cartalat-Carel, S; Chinot, O; Cougnard, J; Delattre, JY; Djafari, L; Duffau, H; Gervais, H; Hoang-Xuan, K; Honnorat, J; Laigle, F; Mokhtari, K; Napolitano, M; Sanson, M; Taillandier, L; Taillibert, S | 1 |
| de Bruin, HG; de Wit, MC; Eijkenboom, W; Sillevis Smitt, PA; van den Bent, MJ | 1 |
| Allgeier, A; Brandes, AA; Enting, RH; Frenay, M; Kros, JM; Menten, J; Stege, EB; Taphoorn, MJ; Tosoni, A; Triebels, VH; van den Bent, MJ; van Heuvel, I | 1 |
| Brandes, AA; Coria, B; Danieli, D; Ermani, M; Gardiman, M; Iuzzolino, P; Pasetto, LM; Talacchi, A; Tosoni, A; Vastola, F | 1 |
| Gui, QP; Lu, DH; Teng, LH; Xuan, Q | 1 |
| de Bruin, HG; Enting, RH; Kros, JM; Looijenga, LH; Smitt, PA; Stege, EM; van den Bent, MJ; van der Rijt, CD; van Heuvel, I | 1 |
| Branle, F; De Witte, O; Goldman, S; Sadeghi, N; Tang, BN; Wikler, D | 1 |
| Jung, SM; Liau, CT; Tseng, CK; Wei, KC | 1 |
| Nomura, K | 1 |
| Aksoy, S; Cakar, M; Erman, M; Harputluoglu, H; Kilickap, S | 1 |
| Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U | 1 |
| Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F | 1 |
| Khoo, JB; Rao, JP; See, SJ; Ty, AU; Wong, MC | 1 |
| Guglani, S; Hopkins, K; Jones, R; Kirkup, M | 1 |
| Dichgans, J; Dietz, K; Fischer, J; Herrlinger, U; Schmidt, F; Weller, M | 1 |
| Abrey, LE; Bayer, R; Cairncross, JG; Childs, BH; DeAngelis, LM; Finlay, JL; Forsyth, P; Gardner, S; Hu, W; Kaminer, L; Macdonald, DR; Nimer, SD; Paleologos, N; Peterson, K; Ramsay, DA; Rosenfeld, S; Salzman, D; Smith, AM; Stewart, D; Swinnen, L; Weaver, S | 1 |
| Fu, P; Mwanda, WO; Ness, A; Orem, J; Remick, SC | 1 |
| Abonour, R; Cornetta, K; Croop, J; Dropcho, E; Erickson, LC; Kieran, MW; Kreissman, S; Reeves, L; Williams, DA | 1 |
| Brandes, AA; Ermani, M; Gardiman, M; Ghimenton, C; Iuzzolino, P; Nicolardi, L; Reni, M; Rotilio, A; Sotti, G; Tosoni, A | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Smith, T; Walker, C; Warnke, PC | 1 |
| Gilbert, MR; Lang, FF | 1 |
| Berkey, B; Brachman, D; Buckner, J; Cairncross, G; Curran, W; Fink, K; Jenkins, R; Laperierre, N; Mehta, M; Scheithauer, B; Shaw, E; Souhami, L | 1 |
| Allgeier, A; Bernsen, HJ; Brandes, AA; Carpentier, AF; Frenay, M; Gorlia, T; Grisold, W; Haaxma-Reiche, H; Kros, JM; Lacombe, D; Sanson, M; Sipos, L; Taphoorn, MJ; Tijssen, CC; van den Bent, MJ; van Kouwenhoven, MC; Vecht, CJ | 1 |
| Landi, A; Piccirilli, M; Salvati, M | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitzki, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Akalan, N; Akyüz, C; Atahan, L; Büyükpamukçu, M; Kutluk, T; Selek, U; Söylemezoglu, F; Varan, A; Yalçin, B | 1 |
| Cartalat-Carel, S; Catenoix, H; Chapuis, F; Honnorat, J; Nighoghossian, N; Trouillas, P | 1 |
| Bourg, V; Chanalet, S; Fauchon, F; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Paquis, P; Ramaioli, A; Vandenbos, F | 1 |
| Hong, YK; Jeun, SS; Kim, BS; Kim, MC; Lee, KS; Lee, TK; Lee, YS; Park, CK; Yang, SH; Yoon, SC | 1 |
| van den Bent, MJ | 3 |
| Allgeier, A; Bernsen, HJ; Bottomley, A; Brandes, AA; Coens, C; Delattre, JY; Frénay, M; Lacombe, D; Mauer, ME; Sillevis Smitt, PA; Taphoorn, MJ; Tijssen, CC; van den Bent, MJ | 1 |
| Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T | 1 |
| Abrey, LE; Cairncross, JG; Forsyth, P; Kewalramani, T; Louis, DN; Mohile, NA; Paleologos, N; Raizer, JJ; Stewart, D | 1 |
| Bogdahn, U; Goerne, R; Hau, P | 1 |
| Ashley, DM; Dobrovic, A; Drummond, KJ; Friedman, HS; Gan, HK; Hawkins, CJ; Johns, TG; Kaye, AH; Lovric, MM; Maxwell, JA; Mikeska, T; Riffkin, CD | 1 |
| Diehl, V; Evens, AM; Hutchings, M | 1 |
| Baumert, BG; Stupp, R | 1 |
| Glas, M; Herrlinger, U; Rasch, K; Weller, M; Wiewrodt, D | 1 |
| Deckert, M; Feuerhake, F; Finke, J; Ihorst, G; Illerhaus, G; Marks, R; Müller, F; Ostertag, C | 1 |
| Allgeier, A; Brandes, AA; Bromberg, JE; Gorlia, T; Grisold, W; Ibdaih, A; Kouwenhoven, MC; Kros, JM; Lacombe, D; Mirimanoff, R; Mokhtari, K; Sipos, L; Teepen, JL; van den Bent, MJ; van Duinen, SG; Vandenbos, F; Vecht, CJ; Wesseling, P | 1 |
| Abdallah, FK; Ayers, LW; Bako, J; Banura, C; Black, J; Fu, P; Johnson, JL; Kakembo, J; Katongole-Mbidde, E; Lederman, MM; Meyerson, HJ; Mwanda, WO; Ness, A; Onyango, CA; Orem, J; Remick, SC; Reynolds, S; Subbiah, V; Wabinga, H; Whalen, CC | 1 |
| Graf, E; Nikkhah, G; Ostertag, C; Tilgner, J; Trippel, M; Vesper, J; Wille, C | 1 |
| Konishi, N; Nakamura, M; Nakase, H; Shimada, K | 1 |
| Bartels, U; Bouffet, E; Buncic, JR; Hargrave, D; Mabbott, D; Nicolin, G; Parkin, P; Rutka, J; Tabori, U | 1 |
| Brachman, D; Buckner, J; Cairncross, G; Curran, W; Fink, K; Jenkins, R; Laperriere, N; Mehta, M; Scheithauer, B; Shaw, E; Souhami, L; Wang, M | 1 |
| DeAngelis, LM | 1 |
| Brandes, AA; Dinjens, WN; Dubbink, HJ; Frenay, M; Gorlia, T; Hegi, M; Ibdaih, A; Jeuken, JW; Kros, JM; Lacombe, D; Sanson, M; Taphoorn, MJ; van den Bent, MJ; van der Lee-Haarloo, CR | 1 |
| Bamberg, M; Engel, C; Ernemann, U; Felsberg, J; Hartmann, C; Ketter, R; Koeppen, S; Kortmann, RD; Meisner, C; Meyermann, R; Pietsch, T; Rapp, M; Reifenberger, G; Sabel, MC; Stockhammer, F; Stoffels, M; von Deimling, A; Weller, M; Wick, W; Wiestler, OD | 1 |
| Delashaw, JB; Doolittle, ND; Gahramanov, S; Guillaume, DJ; Hedrick, NA; Neuwelt, EA | 1 |
| Brandes, AA; Dinjens, WN; Dubbink, HJ; Frenay, M; Gorlia, T; Idbaih, A; Kros, JM; Lacombe, D; Marie, Y; Sanson, M; Taphoorn, MJ; Tijssen, CC; van den Bent, MJ; van Marion, R; Wesseling, P | 1 |
| Banerjee, A; Berger, MS; Gupta, N; Haas-Kogan, DA; Lamborn, K; Mishra, KK; Prados, MD; Squire, S; Wara, WM | 1 |
| Agha, CA; Elias, DA; Fathallah-Shaykh, HM; Hassan, A; Ibrahim, S | 1 |
| Cartalat-Carel, S; Ducray, F; Frappaz, D; Guyotat, J; Honnorat, J; Jouanneau, E; Jouvet, A; Meyronet, D; Mokhtari, K; Pallud, J; Peyre, M; Ricard, D; Sunyach, MP | 1 |
| Kim, JH; Kim, ST; Kim, WS; Kong, DS; Kwon, KH; Lee, JI; Lim, DH; Nam, DH; Park, K; Suh, YL | 1 |
| Broët, P; Carpentier, C; Dalmasso, C; Delattre, JY; Delattre, O; French, P; Gorlia, T; Hoang-Xuan, K; Idbaih, A; Jeuken, J; Kouwenhoven, M; Kros, JM; Mokhtari, K; Sanson, M; Teepen, J; van den Bent, M | 1 |
| Beall, S; Brada, M; Collins, VP; Erridge, S; Gabe, R; Gattamaneni, R; Hopkins, K; Lee, SM; Levy, D; Rampling, R; Saran, F; Stenning, S; Thompson, LC | 1 |
| Bailey, DB; Balkman, CE; Barlow, LL; Barnard, SM; Flory, AB; Intile, JL; Kiselow, MA; Malone, EK; Rassnick, KM; Waite, AH | 1 |
| Ducray, F; Gorlia, T; Hoang-Xuan, K; Idbaih, A; Kros, JM; Mokhtari, K; Sanson, M; Taphoorn, M; Van den Bent, M; Wesseling, P | 1 |
| Finke, J; Fritsch, K; Hader, C; Haug, S; Haug, V; Ihorst, G; Illerhaus, G; Kasenda, B; Nikkhah, G; Prinz, M | 1 |
| Bartels, U; Bouffet, E; Dirks, P; Fried, I; Hawkins, C; Huang, A; Scheinemann, K; Tabori, U; Tsangaris, E | 1 |
| Abrey, LE; Aldape, KD; Ashby, LS; Cairncross, JG; Chamberlain, MC; Cloughesy, TF; DeAngelis, LM; Eichler, AF; Fisher, BJ; Green, RM; Iwamoto, FM; Jhanwar, SC; Kamar, FG; Lassman, AB; Ligon, KL; Louis, DN; Mason, WP; Paleologos, NA; Panageas, KS; Rivera, AL; Robins, HI; Rocque, BG; Roldán, GB; Rosenblum, MK; Schiff, D; Weaver, SA; Wen, PY | 1 |
| Bähr, O; Bamberg, M; Felsberg, J; Fimmers, R; Glas, M; Herrlinger, U; Nägele, T; Rasch, K; Reifenberger, G; Rieger, J; Schabet, M; Simon, M; Steinbach, JP; Urbach, H; Weller, M; Wiewrodt, D | 1 |
| Choquet, S; Elhallani, S; Gonzalez-Aguilar, A; Hoang-Xuan, K; Houillier, C; Idbaih, A; Kaloshi, G; Navarro, S; Omuro, A; Ricard, D; Sierra Del Rio, M; Soussain, C | 1 |
| Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S | 1 |
| Ducray, F | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Baldini, L; Bellei, M; Bordonaro, R; Chisesi, T; Federico, M; Gobbi, P; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Merli, F; Montanini, A; Pavone, V; Pesce, EA; Stelitano, C; Vitolo, U | 1 |
| Ater, JL; Booth, TN; Freyer, DR; Holmes, E; Lazarus, KH; Mazewski, CM; Packer, RJ; Pollack, IF; Prados, M; Sposto, R; Vezina, G; Wisoff, JH; Zhou, T | 1 |
| Barger, GR; Brachman, DG; Brown, PD; Buckner, JC; Coons, SW; Gilbert, MR; Mehta, MP; Shaw, EG; Stelzer, KJ; Wang, M | 1 |
| Ducray, F; Lekoubou, A; Viaccoz, A | 1 |
| Printz, C | 1 |
| Allgeier, A; Bernsen, HJ; Brandes, AA; Delattre, JY; Dinjens, WN; Enting, RH; Frenay, M; French, PJ; Gorlia, T; Grisold, W; Hoang-Xuan, K; Kouwenhoven, MC; Kros, JM; Lacombe, D; Sipos, L; Taphoorn, MJ; Tijssen, CC; van den Bent, MJ; Vecht, CJ | 1 |
| Brachman, D; Buckner, J; Cairncross, G; Curran, W; Fink, K; Jenkins, R; Laperriere, N; Mehta, M; Shaw, E; Souhami, L; Wang, M | 1 |
| de Rooi, J; den Dunnen, WF; Eilers, PH; Erdem-Eraslan, L; French, PJ; Gorlia, T; Gravendeel, LA; Idbaih, A; Kros, JM; Sillevis Smitt, PA; Spliet, WG; Teepen, JL; van den Bent, MJ; Wesseling, P | 1 |
| Brodbelt, A; Mallucci, C; Pizer, B; Salehzadeh, A | 1 |
| Lee, EQ; Nayak, L; Reardon, DA; Rosenfeld, MR; Villano, JL; Wen, PY | 1 |
| Bernsen, HJ; Brandes, AA; Delattre, JY; Frénay, M; Gorlia, T; Kouwenhoven, MC; Kros, JM; Lacombe, D; Taphoorn, MJ; Tijssen, CC; van den Bent, MJ | 1 |
| Roth, P; Weller, M; Wick, W | 1 |
| de Rooi, J; den Dunnen, WF; Eilers, PH; Erdem-Eraslan, L; French, PJ; Gorlia, T; Idbaih, A; Kros, JM; Sillevis Smitt, PA; Spliet, WG; Tijssen, C; van den Bent, MJ; Wesseling, P | 1 |
| Barger, GR; Brachman, DG; Brown, PD; Buckner, JC; Gilbert, MR; Hu, C; Mehta, MP; Prabhu, RS; Shaw, EG; Stelzer, KJ; Won, M | 1 |
| Brachman, DG; Buckner, JC; Cairncross, JG; Curran, WJ; Fink, KL; Giannini, C; Huse, JT; Jenkins, RB; Laperriere, NJ; Mehta, MP; Shaw, EG; Souhami, L; Wang, M | 1 |
| Behrend, SW | 1 |
| Chapet, S; Lévy, S; Mazeron, JJ | 1 |
| Jamali, T; Rizvi, N; Tanzil, S | 1 |
| Bottomley, A; Coens, C; Dirven, L; Ediebah, DE; Galindo-Garre, F; Reijneveld, JC; Ringash, J; Taphoorn, MJ; Uitdehaag, BM; van den Bent, MJ; Zikos, E | 1 |
| Bromberg, JE; Dinjens, WN; Kros, JM; Sillevis Smitt, PA; Taal, W; van den Bent, MJ; van der Rijt, CC; van Heuvel, I; Wertenbroek, AA | 1 |
| Dixit, S; Hingorani, M | 1 |
| Rinne, ML; Wen, PY | 1 |
| Almeida, DS; Caeiro, C; Carvalho, BF; Castro, L; Costa, A; Damasceno, M; Fernandes, AC; Linhares, P; Osório, L; Sampaio, LV; Vaz, RC | 1 |
| De Groot, J; Liu, D; Shonka, N; Smith, L; Webre, C | 1 |
| Lassman, AB | 1 |
| Akalan, N; Akyuz, C; Cengiz, M; Eren, G; Gurkaynak, M; Ozyigit, G; Varan, A; Yazici, G; Yüce, D; Zorlu, F | 1 |
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| Abuali, I; Grossman, SA; Lu, Y; Strowd, RE; Ye, X | 1 |
| Bartolotti, M; Brandes, AA; Franceschi, E; Tosoni, A | 1 |
| Ducray, F; Honnorat, J; Mazzocco, P; Ribba, B | 1 |
| Bahary, JP; Barger, GR; Bell, EH; Brachman, D; Brown, PD; Buckner, JC; Bullard, D; Chakravarti, A; Coons, S; Curran, WJ; Fisher, BJ; Gilbert, MR; Kim, H; Mehta, MP; Murtha, AD; Pugh, SL; Ricci, P; Schultz, CJ; Shaw, EG; Stelzer, K; Suh, JH; Won, M | 1 |
| Felsberg, J; Gramatzki, D; Hentschel, B; Hofer, S; Krex, D; Reifenberger, G; Roth, P; Rushing, EJ; Schnell, O; Simon, M; Weller, M; Westphal, M; Wick, W | 1 |
| Combs, SE; Meyer, B; Schmidt-Graf, F | 1 |
| Brown, PM; Langova, V; Nguyen, S; Tzannes, S; White, J | 1 |
| Bendavid, E; Chang, DT; Chin, AL; Durkee, BY; Harris, JP; Kim, H; Kumar, KA; Maruyama, S; Owens, DK; Pitt, A; Pollom, EL; Qian, Y; Soltys, SG | 1 |
| Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL | 1 |
| Amores-Fuster, I; Blackwood, L; Finotello, R; Harper, A; Killick, DR; Maddox, TW; Mason, SL; Tanis, JB | 1 |
| Wick, W; Winkler, F | 1 |
| Griffin, A; Morgan, E; O'Connell, K; Thomson, M | 1 |
| Castro-Martinez, E; Gonzalez-Aguilar, A; Guerrero-Juarez, V; Gutierrez-Aceves, A; Hernandez-Hernandez, A; Lopez-Martinez, M; Peiro-Osuna, RP; Reyes-Moreno, I; Santos-Zambrano, J | 1 |
| Atkins, KM; Dietrich, J; Loeffler, JS; McDuff, SGR; Oh, KS; Shih, HA | 1 |
| Bartels, UK; Bouffet, E; Hawkins, C; Nobre, L; Raswoli, M; Tabori, U | 1 |
| Cai, Y; Jiang, YG; Jiang, ZH; Tan, ZG; Wang, M | 1 |
| Bronniman, C; Carpentier, C; Ciron, DL; Dehais, C; Ducray, F; Esteyrie, V; Figarella-Branger, D; Martin, E; Moyal, EC; Network, P; Pouessel, D; Uro-Coste, E | 1 |
| Aslam, R; Breathnach, OS; Coyne, Z; Grogan, L; Hennessy, BT; Hennessy, MA; Keogh, RJ; Morris, PG | 1 |
| Egensperger, R; Karschnia, P; Katzendobler, S; Lietke, S; Suchorska, B; Thon, N; Tonn, JC; Weller, J; Weller, M | 1 |
| Blaxill, J; Buzzacott, P; Finlay, J | 1 |
| Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E | 1 |
| Baumann, L; Bendszus, M; Combs, S; Dormann, A; Haut, T; Kessler, T; Kieser, M; Koch, M; Limprecht, R; Merkle-Lock, J; Pertz, M; Platten, M; Sahm, F; Sander, A; Schlegel, U; Selkrig, N; Walter, S; Wick, A; Wick, W; Winkler, F | 1 |
| Aichholzer, M; Berghoff, AS; Dieckmann, K; Furtner, J; Goldberger, S; Hatziioannou, T; Heller, G; Leibetseder, A; Mair, MJ; Pichler, J; Preusser, M; Puhr, R; Tomasich, E; von Oertzen, T; Weis, S; Widhalm, G; Wöhrer, A | 1 |
| Boutet, C; Carpentier, C; Dehais, C; Di Stefano, AL; Ducray, F; Esparragosa Vazquez, I; Figarella-Branger, D; Forest, F; Larrieu-Ciron, D; Meyronet, D; Ndiaye, M; Picart, T; Rivoirard, R; Seyve, A; Vassal, F; Younan, N | 1 |
48 review(s) available for procarbazine and lomustine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemotherapy: the agents in current use.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Glioma; Humans; Lomustine; Medulloblastoma; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Semustine; Teniposide; Vincristine | 1975 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; Humans; Laparotomy; Lomustine; Mechlorethamine; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prospective Studies; Radiotherapy; Splenectomy; Survival Analysis; Vinblastine; Vincristine | 1992 |
Aggressive oligodendroglioma: a chemosensitive tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Humans; Lomustine; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Vincristine | 1992 |
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Minnesota; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Vinblastine; Vincristine | 1990 |
Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Mitomycin; Mitomycins; Neoplasm Staging; Peptichemio; Prednisone; Procarbazine; Prognosis; Vincristine | 1985 |
[Results of the treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
The role of radiation therapy in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Random Allocation; Time Factors; Vincristine; Whole-Body Irradiation | 1985 |
Current chemotherapy of small cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1986 |
Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; Lomustine; Male; Mediastinal Neoplasms; Neoplasms, Radiation-Induced; Osteosarcoma; Prednisone; Procarbazine; Radiotherapy; Vinblastine | 1988 |
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Mutation; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine | 1984 |
[Polychemotherapy and radiotherapy for small cell cancer of the lung].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Methylnitrosourea; Prednisone; Procarbazine; Vincristine | 1983 |
Management of small cell cancer: intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1984 |
Oral therapy for small cell lung cancer.
Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine | 1995 |
Aggressive oligodendroglioma: a chemosensitive tumor.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Glioma; Humans; Lomustine; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Salvage Therapy; Vincristine; Vindesine | 1994 |
Carcinoma of the choroid plexus: a pediatric experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Choroid Plexus Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Lomustine; Male; Procarbazine; Remission Induction; Treatment Outcome; Vincristine | 1993 |
Optimal control of cyclophosphamide-induced emesis.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorouracil; Humans; Lomustine; Methotrexate; Procarbazine; Randomized Controlled Trials as Topic; Vomiting | 1996 |
Acute leukemia following treatment of malignant glioma.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Fatal Outcome; Female; Glioma; Humans; Leukemia, Myeloid; Lomustine; Male; Neoplasms, Second Primary; Procarbazine; Vincristine | 1998 |
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1998 |
Chemotherapy of low-grade gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Humans; Lomustine; Middle Aged; Neoplasm Staging; Oligodendroglioma; Procarbazine; Salvage Therapy; Vincristine | 2001 |
Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Lomustine; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Treatment Outcome; Vincristine | 2001 |
Chemotherapy for the treatment of oligodendroglial tumors.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Dacarbazine; Humans; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Temozolomide; Vincristine | 2001 |
PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy; Retrospective Studies; Vincristine | 2001 |
[Chemo-radiotherapy for malignant brain tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Glioma; Humans; Lomustine; Lymphoma; Medulloblastoma; Oligodendroglioma; Prednisone; Procarbazine; Survival Rate; Vincristine | 2002 |
Adults with newly diagnosed high-grade gliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Contraindications; Cranial Irradiation; Craniotomy; Dacarbazine; Disease Progression; Epidemiologic Methods; Glioblastoma; Humans; Isotretinoin; Lomustine; Palliative Care; Procarbazine; Radiosurgery; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Temozolomide; Treatment Outcome; Vincristine | 2001 |
Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Damage, Chronic; Brain Injuries; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Employment; Female; France; Glioma; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Psychological Tests; Quality of Life; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Social Adjustment; Surveys and Questionnaires; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 2003 |
Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Humans; Incidence; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Temozolomide; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2003 |
Oligodendroglioma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Dexamethasone; Dose Fractionation, Radiation; Emergency Medical Services; Humans; Life Style; Lomustine; Oligodendroglioma; Procarbazine; Vincristine | 2003 |
The role of PCV chemotherapy in the treatment of central neurocytoma: illustration of a case and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Lomustine; Neurocytoma; Procarbazine; Vincristine | 2003 |
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Procarbazine; Temozolomide; Vincristine | 2004 |
[The molecular genetics of oligodendroglioma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 9; Humans; Lomustine; Loss of Heterozygosity; Oligodendroglioma; Procarbazine; Prognosis; Vincristine | 2004 |
[Brief review of the neuro oncology for recent three decades in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Brain Neoplasms; Humans; Immunotherapy; Lomustine; Magnetic Resonance Imaging; Magnetoencephalography; Medical Oncology; Procarbazine; Stem Cell Transplantation; Tomography, X-Ray Computed; Vincristine | 2005 |
Anaplastic oligodendroglioma and oligoastrocytoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Humans; Lomustine; Magnetic Resonance Imaging; Neurosurgical Procedures; Oligodendroglioma; Procarbazine; Prognosis; Vincristine | 2007 |
Procarbazine--a traditional drug in the treatment of malignant gliomas.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials as Topic; Drug Interactions; Glioma; Humans; Lomustine; Procarbazine; Vincristine | 2008 |
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 2008 |
[Clinicopathological diagnosis of gliomas by genotype analysis].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Genotype; Glioblastoma; Humans; Lomustine; Loss of Heterozygosity; Molecular Diagnostic Techniques; Pharmacogenetics; Procarbazine; Prognosis; Temozolomide; Tumor Suppressor Proteins; Vincristine | 2009 |
Chemotherapy for diffuse low-grade gliomas in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 2011 |
Chemotherapy in low-grade gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Clinical Trials as Topic; Dacarbazine; Glioma; Humans; Lomustine; Procarbazine; Temozolomide; Treatment Outcome; Vincristine | 2012 |
[Management of gliomas].
Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Chromosome Deletion; Chromosomes, Human, Pair 1; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Drug Resistance, Neoplasm; Glioma; Humans; Lomustine; Methylation; Multicenter Studies as Topic; Neoplasm Proteins; Neurosurgical Procedures; O(6)-Methylguanine-DNA Methyltransferase; Procarbazine; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Temozolomide; Treatment Outcome; Vincristine | 2014 |
Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.
Topics: Antineoplastic Agents; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Glioma; Humans; Lomustine; Male; Procarbazine; Survival Rate; Treatment Outcome; Vincristine | 2014 |
Low-grade gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Glioma; Humans; Isocitrate Dehydrogenase; Lomustine; Mutation; Procarbazine; Temozolomide; Treatment Outcome; Vincristine | 2015 |
Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Humans; Lomustine; Oligodendroglioma; Procarbazine; Temozolomide; Treatment Outcome; Vincristine | 2015 |
Nitrosoureas in the Management of Malignant Gliomas.
Topics: Dacarbazine; Glioma; Humans; Lomustine; Nitrosourea Compounds; Organophosphorus Compounds; Procarbazine; Temozolomide; Vincristine | 2016 |
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Glioma; Humans; Hydroxyurea; Lomustine; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Randomized Controlled Trials as Topic; Temozolomide; Vincristine | 2017 |
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Glioma; Humans; Isocitrate Dehydrogenase; Lomustine; Mutation; Neoplasm Grading; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Temozolomide; Vincristine | 2020 |
155 trial(s) available for procarbazine and lomustine
| Article | Year |
|---|---|
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Procarbazine; Triazines | 1978 |
Combination chemotherapy of advanced lung cancer: a randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukopenia; Lomustine; Lung Neoplasms; Male; Mechlorethamine; Methotrexate; Middle Aged; Procarbazine; Thrombocytopenia; Vincristine | 1976 |
Role of radiation therapy in combination with chemotherapy in extensive oat cell cancer of the lung: a randomized study.
Topics: Aged; Antineoplastic Agents; Brain; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Procarbazine; Vincristine | 1977 |
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Thymosin; Thymus Hormones; Vincristine | 1979 |
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission, Spontaneous; Vincristine | 1979 |
[A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
Topics: Adult; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Random Allocation; Remission, Spontaneous; Teniposide; Time Factors | 1978 |
Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine | 1979 |
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Topics: Administration, Oral; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Nitrosourea Compounds; Prednisone; Procarbazine; Semustine; Vinblastine | 1976 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1992 |
Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Glioblastoma; Humans; Lomustine; Neoplasm Recurrence, Local; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1992 |
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide; Vincristine | 1992 |
[Early results of the treatment of Hodgkin's disease in adults using the seven-drug cytostatic protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protocols; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Time Factors; Vinblastine; Vincristine | 1992 |
A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
Topics: Adenocarcinoma; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Radiation Dosage; Remission Induction; Survival Analysis; Vinblastine; Vincristine | 1992 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Vinblastine | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; Humans; Laparotomy; Lomustine; Mechlorethamine; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prospective Studies; Radiotherapy; Splenectomy; Survival Analysis; Vinblastine; Vincristine | 1992 |
External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Combined Modality Therapy; Craniotomy; Female; Glioblastoma; Glioma; Humans; Iodine Radioisotopes; Lomustine; Male; Middle Aged; Procarbazine; Retrospective Studies; Vincristine | 1991 |
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Drug Evaluation; Female; Glioblastoma; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Survival Analysis; Vincristine | 1991 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine | 1990 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Streptozocin; Survival Rate; Vincristine | 1991 |
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisolone; Prednisone; Procarbazine; Survival Rate; Vincristine | 1991 |
A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Multivariate Analysis; Procarbazine; Prognosis; Prospective Studies; Quality of Life; Supratentorial Neoplasms; Survival Rate; Vincristine | 1991 |
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Combined Modality Therapy; Glioblastoma; Glioma; Humans; Lomustine; Middle Aged; Multicenter Studies as Topic; Procarbazine; Prognosis; Randomized Controlled Trials as Topic; United States; Vincristine | 1990 |
Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1990 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine | 1986 |
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials as Topic; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Lymph Nodes; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Random Allocation; Sclerosis; Streptozocin; Vinblastine; Vincristine | 1986 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine | 1986 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine | 1987 |
[Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Clinical Trials as Topic; Daunorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 1989 |
A randomized clinical trial comparing systemic radiotherapy versus chemotherapy versus local radiotherapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Radionuclide Imaging; Radiotherapy, High-Energy; Random Allocation; Vincristine | 1989 |
The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Dexamethasone; Glioblastoma; Humans; Lomustine; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Random Allocation; Vincristine | 1989 |
[Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Hodgkin Disease; Humans; Lomustine; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Vinblastine; Vincristine | 1989 |
The role of radiation therapy in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Random Allocation; Time Factors; Vincristine; Whole-Body Irradiation | 1985 |
Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Hydroxyurea; Lomustine; Male; Middle Aged; Procarbazine; Vincristine | 1985 |
Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Prognosis; Prospective Studies; Pulmonary Fibrosis; Radiography; Random Allocation; Respiratory Function Tests; Vincristine | 1986 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Infant; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Random Allocation; Remission Induction; Statistics as Topic; Vinblastine | 1988 |
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Germany, West; Hodgkin Disease; Humans; Laparotomy; Lomustine; Lymphatic Metastasis; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Splenectomy; Vinblastine; Vincristine | 1988 |
The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1987 |
Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Procarbazine; Prospective Studies; Random Allocation; Skin Neoplasms; Vindesine | 1986 |
[Treatment of patients with lymphogranulomatosis, stages I and II (preliminary results of a randomized study--radiation and complex therapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Hodgkin Disease; Humans; Lomustine; Lymph Nodes; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Random Allocation; Vinblastine | 1985 |
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Laparotomy; Lomustine; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1985 |
Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group Report.
Topics: Brain Neoplasms; Combined Modality Therapy; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prognosis; Radiotherapy, High-Energy | 1983 |
Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Random Allocation; Vincristine | 1984 |
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
Topics: Adult; Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Vincristine | 1982 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vinblastine; Vincristine | 1983 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1984 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine | 1984 |
A controlled clinical trial testing two potentially non-cross-resistant chemotherapeutic regimens in small-cell carcinoma of the lung.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Prognosis; Time Factors | 1981 |
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1982 |
Chemotherapy of small cell carcinoma of the lung: comparison of a cyclic alternative combination with simultaneous combinations of four and seven agents.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1981 |
Early crossover of induction chemotherapy in small cell lung carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Prospective Studies; Vincristine | 1983 |
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Nitrosourea Compounds; Prednisone; Procarbazine; Prognosis; Prospective Studies; Random Allocation; Vinblastine; Vincristine | 1983 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Random Allocation; Recurrence; Retrospective Studies; Risk; Time Factors; Vinblastine; Vincristine | 1984 |
Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combined Modality Therapy; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 1984 |
[Combined treatment of malignant gliomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cobalt Radioisotopes; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radioisotope Teletherapy; Vincristine | 1983 |
Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Nitrosourea Compounds; Prednisone; Procarbazine; Vinblastine | 1981 |
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Splenectomy; Vinblastine; Vincristine | 1982 |
Chemotherapy of extensive large cell and adenocarcinoma of the lung: a randomized trial in 210 patients.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Probability; Procarbazine; Prognosis; Time Factors | 1980 |
Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Procarbazine; Prospective Studies; Random Allocation; Teniposide | 1981 |
Hodgkin's disease in childhood: therapy results in Argentina.
Topics: Adolescent; Antineoplastic Agents; Argentina; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Random Allocation; Vinblastine | 1981 |
Primary intracranial gliomas: clinical studies and treatment regimens of the Brain Tumor Research Center, University of California, San Francisco, 1977-1979.
Topics: Antineoplastic Agents; Brain Neoplasms; California; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Glioma; Humans; Hydroxyurea; Lomustine; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1981 |
A review of studies of the EORTC brain tumor group.
Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Lomustine; Middle Aged; Procarbazine; Teniposide | 1981 |
Chemotherapy for medulloblastoma in children. Current status and future prospects.
Topics: Adolescent; Cerebellar Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Infant; Lomustine; Medulloblastoma; Nitrosourea Compounds; Procarbazine; Random Allocation; Vincristine | 1982 |
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematopoiesis; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Prospective Studies; Vinblastine | 1980 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine | 1994 |
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Glioblastoma; Humans; Lomustine; Middle Aged; Procarbazine; Survival Analysis; Vincristine | 1995 |
Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Disease-Free Survival; Glioblastoma; Humans; Lomustine; Middle Aged; Procarbazine; Vincristine | 1995 |
Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neutropenia; Procarbazine; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Canada; Cerebral Hemorrhage; Disease-Free Survival; Female; Hematoma, Subdural; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Vincristine | 1994 |
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1994 |
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Lomustine; Methotrexate; Middle Aged; Procarbazine; Quality of Life | 1993 |
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Hearing Loss; Humans; Hydroxyurea; Incidence; Infant; Lomustine; Male; Methylprednisolone; Procarbazine; Radiation Injuries; Risk Factors; Vincristine | 1996 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 1995 |
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Glioma; Humans; Infant; Lomustine; Male; Mitolactol; Procarbazine; Thioguanine; Treatment Outcome; Vincristine | 1997 |
TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Disease Progression; Female; Fluorouracil; Humans; Hydroxyurea; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitolactol; Procarbazine; Prospective Studies; Thioguanine | 1997 |
Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas.
Topics: Adult; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cohort Studies; Female; Humans; Injections, Intravenous; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Paclitaxel; Procarbazine; Salvage Therapy; Thrombocytopenia; Vincristine | 1997 |
Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Topics: Adolescent; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Interferon-alpha; Karnofsky Performance Status; Leucovorin; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1998 |
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Vinblastine | 1998 |
Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Female; Glioma; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lomustine; Male; Procarbazine; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Cognition; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Reoperation; Vincristine | 1999 |
Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiotherapy, High-Energy; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 1999 |
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Disease Progression; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Proportional Hazards Models; Radiation-Sensitizing Agents; Survival Analysis; Vincristine | 1999 |
PCV salvage chemotherapy for recurrent primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Humans; Lomustine; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2000 |
Quantitative 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Vincristine | 2000 |
A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease-Free Survival; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Prospective Studies; Retrospective Studies; Time Factors; Vincristine | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Eflornithine; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prospective Studies; Time Factors; Vincristine; Vindesine | 2000 |
Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Proportional Hazards Models; Survival Analysis; Vincristine | 2001 |
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Etoposide; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Procarbazine; Prognosis; Quality of Life; Recombinant Proteins; Survival Rate; Treatment Outcome | 2001 |
Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Glioma; Humans; Lomustine; Male; Mitolactol; Procarbazine; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2000 |
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cohort Studies; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lomustine; Lymphatic Irradiation; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Survival Analysis; Vincristine | 2002 |
Long-term follow-up in managing anaplastic astrocytoma by multimodality approach with surgery followed by postoperative radiotherapy and PCV-chemotherapy: phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Multivariate Analysis; Neurosurgical Procedures; Procarbazine; Radiotherapy Dosage; Survival Analysis; Vincristine | 2002 |
Concurrent modified PCV chemotherapy and radiotherapy in newly diagnosed grade IV astrocytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prognosis; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Up-Regulation; Vinblastine; Vincristine | 2002 |
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Humans; In Situ Hybridization, Fluorescence; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Vincristine | 2003 |
A prospective study on glioblastoma in the elderly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Lomustine; Male; Neurosurgical Procedures; Procarbazine; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Temozolomide; Vincristine | 2003 |
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Temozolomide; Treatment Outcome; Vincristine | 2003 |
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biopsy, Needle; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Spinal; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasm Staging; Probability; Procarbazine; Research; Risk Assessment; Survival Analysis; Treatment Outcome | 2003 |
Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Disease Progression; Drug Administration Schedule; Drug Tolerance; Female; Glioma; Humans; Infant; Lomustine; Male; Neoplasm Recurrence, Local; Procarbazine; Salvage Therapy; Thioguanine; Treatment Outcome; Vincristine | 2003 |
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Prognosis; Prospective Studies; Survival Rate; Thiotepa; Vincristine | 2003 |
Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Treatment Outcome; Vincristine | 2004 |
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Vincristine | 2004 |
Initial chemotherapy in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Karnofsky Performance Status; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Procarbazine; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine | 2004 |
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Procarbazine; Temozolomide; Vincristine | 2004 |
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cohort Studies; Dacarbazine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Remission Induction; Retrospective Studies; Salvage Therapy; Sequence Deletion; Temozolomide; Treatment Outcome; Vincristine | 2004 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2006 |
Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asian People; Brain Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lomustine; Male; Oligodendroglioma; Procarbazine; Survival Analysis; Vincristine | 2006 |
PCV chemotherapy for recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Recurrence; Time Factors; Vincristine | 2006 |
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Survival Analysis; Thiotepa; Treatment Outcome; Vincristine | 2006 |
Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Middle Aged; Procarbazine; Survival Analysis | 2005 |
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Colony-Forming Units Assay; DNA Primers; Female; Fibronectins; Genetic Therapy; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Humans; Lomustine; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Polymerase Chain Reaction; Procarbazine; Retroviridae; Transduction, Genetic; Vincristine | 2006 |
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dose Fractionation, Radiation; Female; Humans; Lomustine; Loss of Heterozygosity; Male; Middle Aged; Oligodendroglioma; Procarbazine; Proportional Hazards Models; Radiotherapy, High-Energy; Survival Analysis; Vincristine | 2006 |
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer p
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dose Fractionation, Radiation; Female; Humans; Lomustine; Loss of Heterozygosity; Male; Middle Aged; Oligodendroglioma; Procarbazine; Survival Analysis; Vincristine | 2006 |
Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Procarbazine; Treatment Outcome; Vincristine | 2007 |
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Quality of Life; Radiotherapy; Vincristine | 2007 |
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Busulfan; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine | 2008 |
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Karnofsky Performance Status; Leukopenia; Lomustine; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Procarbazine; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome | 2009 |
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 7; Clinical Trials, Phase III as Topic; Endothelium, Vascular; Humans; In Situ Hybridization, Fluorescence; Lomustine; Necrosis; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Prospective Studies; Survival Rate; Vincristine | 2009 |
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cognition; Combined Modality Therapy; Humans; Karnofsky Performance Status; Lomustine; Longitudinal Studies; Mental Status Schedule; Middle Aged; Oligodendroglioma; Procarbazine; Quality of Life; Survival Analysis; Vincristine | 2010 |
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; CpG Islands; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Europe; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lomustine; Middle Aged; Oligodendroglioma; Polymerase Chain Reaction; Procarbazine; Promoter Regions, Genetic; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Suppressor Proteins; Vincristine | 2009 |
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Female; Glioma; Humans; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Mutation; Procarbazine; Promoter Regions, Genetic; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Temozolomide; Time Factors; Treatment Failure; Tumor Suppressor Proteins; Vincristine; Young Adult | 2009 |
Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Cross-Linking Reagents; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Lomustine; Male; Melphalan; Middle Aged; Oligodendroglioma; Osmotic Pressure; Procarbazine; Temozolomide; Vincristine; Young Adult | 2010 |
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Female; Genes, erbB-1; Humans; In Situ Hybridization, Fluorescence; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Mutation; Oligodendroglioma; Polymerase Chain Reaction; Procarbazine; Prognosis; Promoter Regions, Genetic; Radiotherapy; Treatment Outcome; Tumor Suppressor Proteins; Vincristine; Young Adult | 2010 |
Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Hypothalamic Neoplasms; Infant; Lomustine; Longitudinal Studies; Male; Mitolactol; Predictive Value of Tests; Procarbazine; Retrospective Studies; Salvage Therapy; Thioguanine; Treatment Outcome; Vincristine | 2010 |
Impact of adjuvant chemotherapy for gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Child; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Female; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Neoplasms, Neuroepithelial; Neoplasms, Radiation-Induced; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Vincristine; Young Adult | 2010 |
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Chromosome Aberrations; Chromosomes, Artificial, Bacterial; Combined Modality Therapy; Comparative Genomic Hybridization; Humans; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Multicenter Studies as Topic; Oligodendroglioma; Procarbazine; Prognosis; Proportional Hazards Models; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2011 |
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Glioma; Humans; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Neoplasm Staging; Procarbazine; Proportional Hazards Models; Quality of Life; Recurrence; Risk Assessment; Risk Factors; Temozolomide; Time Factors; Treatment Outcome; United Kingdom; Vincristine | 2010 |
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Female; Lomustine; Lymphoma; Male; Mechlorethamine; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Vincristine | 2010 |
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Intermediate Filament Proteins; Isocitrate Dehydrogenase; Lomustine; Male; Oligodendroglioma; Procarbazine; Prognosis; Proportional Hazards Models; Sequence Deletion; Treatment Outcome; Tumor Suppressor Proteins; Vincristine | 2011 |
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Pilot Projects; Procarbazine; Rituximab; Survival Analysis | 2011 |
Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Infant, Newborn; Lomustine; Male; Procarbazine; Retrospective Studies; Survival Rate; Thioguanine; Vinblastine; Vincristine | 2011 |
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain; Combined Modality Therapy; Disease Progression; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Endpoint Determination; Female; Humans; Karnofsky Performance Status; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Procarbazine; Prognosis; Prospective Studies; Sample Size; Survival Analysis; Treatment Outcome; Tumor Suppressor Proteins | 2011 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 2011 |
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Female; Glioma; Humans; Infant; Lomustine; Male; Multivariate Analysis; Procarbazine; Prognosis; Risk Factors; Spinal Cord Neoplasms; Thioguanine; Treatment Outcome; Vincristine | 2012 |
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Chi-Square Distribution; Disease-Free Survival; Glioma; Humans; Kaplan-Meier Estimate; Lomustine; Middle Aged; Multivariate Analysis; Neoplasm Grading; Procarbazine; Proportional Hazards Models; Risk Assessment; Risk Factors; Supratentorial Neoplasms; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2012 |
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Follow-Up Studies; Gene Deletion; Humans; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Lomustine; Oligodendroglioma; Procarbazine; Vincristine | 2013 |
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease-Free Survival; Gene Deletion; Humans; Kaplan-Meier Estimate; Lomustine; Oligodendroglioma; Procarbazine; Proportional Hazards Models; Radiotherapy; Time; Vincristine | 2013 |
Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC stu
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Procarbazine; Prognosis; Transcriptome; Treatment Outcome; Vincristine; Young Adult | 2013 |
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brai
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Chemotherapy, Adjuvant; Decision Support Techniques; Disease-Free Survival; Europe; Female; Humans; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Multivariate Analysis; Oligodendroglioma; Patient Selection; Procarbazine; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2013 |
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Cognition; Cognition Disorders; Disease-Free Survival; Female; Glioma; Humans; Lomustine; Male; Neoplasm Grading; Procarbazine; Prospective Studies; Survival Rate; Vincristine | 2014 |
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Female; Gene Frequency; Humans; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Multivariate Analysis; Mutation; Odds Ratio; Oligodendroglioma; Patient Selection; Polymorphism, Genetic; Precision Medicine; Procarbazine; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome; Vincristine | 2014 |
Patients with primary brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prospective Studies; Vincristine; Young Adult | 2014 |
Joint modeling of longitudinal health-related quality of life data and survival.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Models, Statistical; Oligodendroglioma; Outcome Assessment, Health Care; Procarbazine; Quality of Life; Surveys and Questionnaires; Time; Treatment Outcome; Vincristine; Young Adult | 2015 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Dacarbazine; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Vincristine | 2016 |
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lomustine; Male; Neoplasm Grading; Oligodendroglioma; Procarbazine; Survival Analysis; Vincristine; Young Adult | 2016 |
[Not Available].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chemoradiotherapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lomustine; Male; Neoplasm Grading; Prevalence; Procarbazine; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome; United States; Vincristine; Young Adult | 2016 |
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Neoplasm Grading; Oligodendroglioma; Procarbazine; Quality of Life; Treatment Outcome; Vincristine | 2022 |
236 other study(ies) available for procarbazine and lomustine
| Article | Year |
|---|---|
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.
Topics: Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Male; Models, Biological; Molecular Weight; Rats; Rats, Inbred F344; Solubility; Structure-Activity Relationship | 1980 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Morphological responses of benign human prostatic hypertrophic tissue to chemotherapeutic agents in an in vitro culture system.
Topics: Aged; Altretamine; Dacarbazine; Fluorouracil; Humans; Lomustine; Male; Microscopy; Middle Aged; Organ Culture Techniques; Procarbazine; Prostate; Prostatic Hyperplasia; Streptozocin; Vincristine | 1975 |
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1976 |
[Chemotherapy in bronchogenic carcinoma (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Bronchogenic; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Procarbazine; Vinblastine | 1977 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Male; Mechlorethamine; Middle Aged; Mutagens; Neoplasms, Multiple Primary; Oxymetholone; Prednisone; Pregnancy; Procarbazine; Razoxane; Teratogens; Vinblastine; Vincristine | 1977 |
[Cytostatic chemotherapy of lymphogranulomatosis].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine | 1978 |
Chemotherapy for lung cancer.
Topics: Bleomycin; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Vinblastine; Vincristine | 1978 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Nitrosourea Compounds; Prednisone; Procarbazine; Recurrence; Time Factors; Vinblastine; Vincristine | 1978 |
Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Bleomycin; Brain Neoplasms; Child; Drug Therapy, Combination; Humans; Lomustine; Middle Aged; Nitrosourea Compounds; Procarbazine | 1978 |
Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine | 1979 |
Effects of cancer chemotherapeutic agents on testicular DNA synthesis in the rat. Evaluation of a short-term test for studies of the genetic toxicity of chemicals and drugs in vivo.
Topics: Animals; Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; DNA; Dose-Response Relationship, Drug; Kinetics; Lomustine; Male; Mutation; Procarbazine; Rats; Testis; Thiotepa; Thymidine | 1979 |
Chemotherapy of invasive thymoma.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Procarbazine; Thymoma; Thymus Neoplasms; Vinblastine; Vincristine | 1976 |
Single-agent chemotherapy of brain tumors. A five-year review.
Topics: Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Carmustine; Glioma; Humans; Imidazoles; Lomustine; Medulloblastoma; Melanoma; Nitrosourea Compounds; Peripheral Nervous System Diseases; Procarbazine; Time Factors; Vincristine | 1976 |
Brain tumors in children.
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Diagnosis, Differential; Ependymoma; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Radiotherapy Dosage; Vincristine | 1978 |
Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Glioma; Humans; Lomustine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Nervous System Diseases; Postoperative Period; Procarbazine; Vincristine | 1978 |
Chemotherapy of experimental metastatic brain tumors in female Wistar rats.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carcinoma 256, Walker; Carotid Arteries; Cells, Cultured; Cyclophosphamide; Disease Models, Animal; Female; Lomustine; Methotrexate; Neoplasm Metastasis; Neoplasms, Experimental; Nitrosourea Compounds; Procarbazine; Rats; Semustine | 1979 |
Development of Hodgkin's disease in a patient receiving procarbazine, CCNU, and vincristine therapy for a gemistocytic astrocytoma.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Middle Aged; Neoplasms, Multiple Primary; Procarbazine; Vincristine | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynecomastia; Herpes Zoster; Hodgkin Disease; Humans; Infant; Lomustine; Male; Mechlorethamine; Prednisone; Procarbazine; Recurrence; Remission, Spontaneous; Time Factors; Uganda; Vincristine | 1978 |
Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Humans; Lomustine; Medulloblastoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Procarbazine; Vincristine | 1978 |
Correlations between experimental chemotherapy in the murine glioma and effectiveness of clinical therapy regimens.
Topics: Animals; Carmustine; Dianhydrogalactitol; Drug Therapy, Combination; Ellipticines; Glioma; Lomustine; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Procarbazine; Time Factors; Transplantation, Homologous | 1978 |
Treatment of adult malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Glioma; Humans; Lomustine; Middle Aged; Procarbazine; Teniposide | 1978 |
Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Topics: Adult; Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vinblastine | 1977 |
Nitrosourea chemotherapy for primary malignant gliomas.
Topics: Brain Neoplasms; Carmustine; Drug Therapy, Combination; Fluorouracil; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Nitrosourea Compounds; Procarbazine; Semustine; Vincristine | 1976 |
Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
Topics: Brain Neoplasms; Drug Evaluation; Drug Therapy, Combination; Glioma; Humans; Lomustine; Nitrosourea Compounds; Procarbazine; Vincristine | 1976 |
Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors.
Topics: Brain Neoplasms; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Lomustine; Neoplasm Metastasis; Nitrosourea Compounds; Procarbazine; Vincristine | 1975 |
Brachytherapy of brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Child; Combined Modality Therapy; Follow-Up Studies; Glioblastoma; Glioma; Humans; Hydroxyurea; Hyperthermia, Induced; Iodine Radioisotopes; Lomustine; Procarbazine; Radiotherapy Dosage; Time Factors; Vincristine | 1992 |
[Results of combined treatment of neoplasms of the posterior cranial fossa in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cerebellar Neoplasms; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; Ependymoma; Female; Humans; Infant; Lomustine; Male; Medulloblastoma; Postoperative Care; Procarbazine; Prognosis; Time Factors; Vincristine | 1992 |
Primary central nervous system lymphoma: a role for adjuvant chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Female; Humans; Hydroxyurea; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Vincristine | 1992 |
Role of radiation therapy in advanced Hodgkin's disease--as yet, an answer? Still a question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; Lomustine; Prednisone; Procarbazine; Vinblastine | 1992 |
The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Administration Schedule; Female; Humans; Lomustine; Male; Middle Aged; Neoplastic Stem Cells; Oligodendroglioma; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1992 |
[Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission Induction; Time Factors; Vincristine | 1991 |
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazine; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Nitroso Compounds; Prednisone; Procarbazine; Sister Chromatid Exchange; Vinblastine; Vincristine | 1990 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine | 1990 |
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Saudi Arabia; Vinblastine; Vincristine | 1991 |
Direct comparison of peripheral T-cell lymphomas with their B-cell counterpart.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Immunophenotyping; Leucovorin; Lomustine; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1991 |
New approaches to the chemotherapy of melanoma.
Topics: Alkaloids; Amifostine; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Daunorubicin; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Paclitaxel; Procarbazine; Tamoxifen; Taurine; Thiotepa; Vincristine; Vindesine | 1991 |
[The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Remission Induction; Splenectomy; Time Factors; Vinblastine | 1991 |
[The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin Disease; Humans; Lomustine; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Vinblastine; Vincristine | 1991 |
Thyroid function after treatment of brain tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Female; Glioma; Humans; Infant; Life Tables; Lomustine; Male; Procarbazine; Radiotherapy Dosage; Regression Analysis; Spinal Cord; Thyroid Diseases; Thyroid Gland; Thyrotropin; Thyroxine; Vincristine | 1991 |
Chemotherapy for oligodendroglioma. Progress report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Vincristine | 1991 |
Adjuvant chemotherapy for primary lymphoma of the central nervous system.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nervous System Neoplasms; Procarbazine; Survival Analysis; Vincristine | 1990 |
The VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.
Topics: Animals; Carmustine; Cell Division; Disease Models, Animal; Drug Screening Assays, Antitumor; Glioma; Lomustine; Mice; Procarbazine; Tumor Cells, Cultured; Vincristine | 1990 |
The chemotherapeutic response of a murine (VM) model of human glioma.
Topics: Animals; Astrocytoma; Brain Neoplasms; Carmustine; Disease Models, Animal; Lomustine; Mice; Mice, Inbred Strains; Procarbazine; Skin Neoplasms; Vincristine | 1990 |
[Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin Disease; Humans; Lomustine; Lung Neoplasms; Mediastinal Neoplasms; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1990 |
Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1990 |
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine | 1986 |
[Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
[Chemotherapy combined with selective resection in small cell lung cancer--analysis of 239 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality Therapy; Cytarabine; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Nitrogen Mustard Compounds; Procarbazine; Vincristine | 1986 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Streptozocin; Vincristine | 1988 |
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Italy; Lomustine; Male; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine | 1988 |
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1988 |
[Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1988 |
Reduced combined radiotherapy and chemotherapy for Hodgkin's disease--risk-adapted treatment approach.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Daunorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine | 1989 |
Third-line salvage chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1985 |
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Melphalan; Methotrexate; Middle Aged; Neoplasms; Procarbazine; Testicular Neoplasms; Vincristine | 1989 |
Ovarian function following chemotherapy for childhood brain tumours.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child; Child, Preschool; Female; Humans; Lomustine; Menarche; Ovary; Procarbazine; Puberty | 1989 |
Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Hodgkin Disease; Humans; Leukocyte Count; Lomustine; Prednisone; Procarbazine; Vinblastine | 1989 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injections, Intralymphatic; Lomustine; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Procarbazine; Prospidium; Remission Induction; Vinblastine; Vincristine | 1989 |
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Cohort Studies; Drug Therapy, Combination; Glioma; Humans; Lomustine; Male; Neoplasm Recurrence, Local; Procarbazine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Results of a combined chemo-radiotherapeutic program in 61 patients affected by small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Radiography; Vincristine; Vomiting | 1988 |
[Antineoplastic chemotherapy for bronchial carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Vinblastine; Vincristine; Vindesine | 1985 |
Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hematologic Diseases; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Peripheral Nervous System Diseases; Procarbazine; Skin Diseases; Skin Neoplasms; Vincristine | 1985 |
[Chemotherapy and combined chemo- and radiotherapy of small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Methylnitrosourea; Procarbazine; Prospidium; Vincristine | 1985 |
Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Vincristine | 1986 |
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Prognosis; Vincristine | 1986 |
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1987 |
[New developments in chemotherapy for experimental brain metastasis].
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Daunorubicin; Doxorubicin; Floxuridine; Hydantoins; Leukemia, Myeloid; Liver Neoplasms, Experimental; Lomustine; Meningeal Neoplasms; Methotrexate; Neoplasm Transplantation; Nimustine; Nitrogen Mustard Compounds; Nitrosourea Compounds; Procarbazine; Rats | 1985 |
[Use of nitrosourea derivatives in the treatment of patients with Hodgkin's disease with lesions of the central nervous system].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Evaluation; Hodgkin Disease; Humans; Lomustine; Methylnitrosourea; Middle Aged; Prednisolone; Procarbazine; Spinal Cord Neoplasms; Vinca Alkaloids | 1988 |
Successful chemotherapy for recurrent malignant oligodendroglioma.
Topics: Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Vincristine | 1988 |
Treatment response in malignant optic glioma of adulthood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cranial Nerve Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Invasiveness; Optic Nerve Diseases; Procarbazine; Vincristine | 1988 |
[Status of the heart during a combined method of treating patients with stage I to II lymphogranulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pericarditis; Pleural Diseases; Prednisone; Procarbazine; Radiography; Radiotherapy Dosage; Retrospective Studies; Tissue Adhesions; Vinblastine; Vincristine | 1988 |
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cytarabine; Cytidine Diphosphate Diglycerides; Dacarbazine; Female; Glioma; Humans; Hydroxyurea; Infant; Lomustine; Male; Medulloblastoma; Methylprednisolone; Procarbazine; Vincristine | 1988 |
Brief chemotherapy associated with extended field radiotherapy in Hodgkin's disease. Long-term results in a series of 102 patients with clinical stages I-IIIA.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine | 1988 |
[Hodgkin's disease. Study of 100 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine | 1987 |
[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Teniposide; Terminal Care | 1986 |
Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Mitolactol; Procarbazine | 1986 |
Metastatic malignant melanoma treated with procarbazine, vincristine and lomustine (POC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Female; Humans; Liver Neoplasms; Lomustine; Lung Neoplasms; Male; Melanoma; Middle Aged; Procarbazine; Skin Neoplasms; Vincristine | 1987 |
[Results of a pilot study of hyaluronidase as an adjunct to cytostatic therapy in malignant diseases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Tolerance; Female; Humans; Hyaluronoglucosaminidase; Lomustine; Male; Mechlorethamine; Methotrexate; Neoplasms; Peptichemio; Pilot Projects; Prednisone; Procarbazine; Vincristine | 1985 |
[The main stages in the complex treatment of children with lymphogranulomatosis (Hodgkin's disease)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lomustine; Lymph Nodes; Male; Neoplasm Staging; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Splenectomy; Vinblastine; Vincristine | 1985 |
Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cells, Cultured; Female; Glioma; Humans; Lomustine; Male; Methionine; Middle Aged; Procarbazine; Prognosis; Time Factors; Vincristine | 1985 |
Chemosensitivity testing in the treatment of malignant gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioma; Humans; Lomustine; Procarbazine; Vincristine | 1985 |
Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Procarbazine; Radiotherapy Dosage; Vincristine | 1984 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vincristine | 1980 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Recurrence; Vinblastine | 1980 |
Late results of multimodality therapy of high-grade supratentorial astrocytomas.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Bleomycin; Brain Neoplasms; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide | 1981 |
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and dexamethasone].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Vinblastine; Vincristine | 1983 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1983 |
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1983 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Heart Diseases; Hodgkin Disease; Humans; Lomustine; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vinblastine; Vincristine | 1984 |
Combined modality treatment of small cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1981 |
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Procarbazine; Vincristine | 1982 |
Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms, Experimental; Procarbazine; Transplantation, Heterologous; Vincristine | 1982 |
[Polychemotherapy of small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Regression, Spontaneous; Procarbazine; Time Factors; Vincristine | 1983 |
[Adriamycin in the combined chemotherapy of small-cell lung cancer].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Procarbazine; Radiotherapy Dosage; Time Factors; Vincristine | 1983 |
[Triple biphasic chemotherapy in the treatment of small-cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1983 |
Small cell lung cancer and the influence of chemotherapy on CFUcs in bone marrow.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cells; Humans; Lomustine; Lung Neoplasms; Procarbazine; Vincristine | 1984 |
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lomustine; Lymphoma; Male; Middle Aged; Procarbazine; Vincristine | 1984 |
Combination cytotoxic chemotherapy with procarbazine, vincristine, and lomustine (POC) in disseminated malignant melanoma: 8 years' follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Procarbazine; Skin Neoplasms; Vincristine | 1984 |
[3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Gamma Rays; Hodgkin Disease; Humans; Lomustine; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Radioisotope Teletherapy; Radiotherapy Dosage; Splenectomy; Vinblastine; Vincristine | 1984 |
[A combined therapy program for children with lymphogranulomatosis].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lomustine; Lymph Nodes; Male; Neoplasm Staging; Nitrogen Mustard Compounds; Patient Care Planning; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Splenectomy; Vinblastine; Vincristine | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Disease; Humans; Laparotomy; Lomustine; Lymphoma; Male; Mechlorethamine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1984 |
[Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Splenectomy; Vinblastine; Vincristine | 1984 |
[Secondary malignant tumors following treatment of Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Radiation-Induced; Prednisone; Procarbazine; Risk; Sex Factors; Stomach Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vincristine | 1984 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lomustine; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Quality of Life; Recurrence; Vinblastine; Vincristine | 1983 |
Early response to chemotherapy as a prognostic factor in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Neoplasm Staging; Prednisone; Probability; Procarbazine; Prognosis; Time Factors; Vinblastine; Vincristine | 1983 |
[Treatment procedure in generalized lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Splenectomy; Vinblastine; Vincristine | 1982 |
[Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine | 1982 |
Experimental approach for the search of effective drug combination in cancer chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Leukemia L1210; Lomustine; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Procarbazine; Prospidium; Sarcoma, Experimental | 1982 |
In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.
Topics: Abrin; Animals; Antineoplastic Agents; Dacarbazine; Humans; Lomustine; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Procarbazine; Ricin; Vinblastine | 1980 |
[Results of combined modality treatment of malignant gliomas. Comparison of postoperative irradiation, chemotherapy, and combined radio-polychemotherapy (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1981 |
[Pruritus in Hodgkin's disease responding to cimetidine].
Topics: Adult; Cimetidine; Female; Guanidines; Hodgkin Disease; Humans; Lomustine; Prednisone; Procarbazine; Pruritus; Vinblastine | 1981 |
Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report.
Topics: Cerebellar Neoplasms; Child; Drug Therapy, Combination; Humans; Lomustine; Medulloblastoma; Postoperative Care; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vincristine | 1981 |
The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Dacarbazine; Drug Evaluation, Preclinical; Humans; Lomustine; Melanoma; Mice; Neoplasm Transplantation; Procarbazine; Ricin; Transplantation, Heterologous; Vinblastine | 1981 |
Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
Topics: Abrin; Animals; Antineoplastic Agents; Dacarbazine; Humans; Lomustine; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Procarbazine; Ricin; Skin Neoplasms; Time Factors; Transplantation, Heterologous; Vinblastine | 1980 |
Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Middle Aged; Neoplasm Metastasis; Procarbazine; Thrombocytopenia; Vincristine | 1980 |
Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Pilot Projects; Procarbazine; Skin Neoplasms; Time Factors; Vincristine | 1980 |
An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
Topics: Animals; Dacarbazine; Humans; Lomustine; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Procarbazine; Transplantation, Heterologous | 1980 |
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vincristine | 1995 |
Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cytarabine; Epirubicin; Female; Hodgkin Disease; Humans; Laparotomy; Lomustine; Male; Methotrexate; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine | 1994 |
Response and control: lessons from oligodendroglioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Oligodendroglioma; Procarbazine; Remission Induction; Vincristine | 1995 |
Chemoradiation and adjuvant chemotherapy for glioblastoma: why does so much therapy yield so little improvement in survival?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Glioblastoma; Humans; Lomustine; Procarbazine; Vincristine | 1995 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1993 |
Interleukin-2 gene therapy in a patient with glioblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cells, Cultured; Combined Modality Therapy; Fatal Outcome; Female; Fibroblasts; Genetic Therapy; Genetic Vectors; Glioblastoma; Humans; Injections, Subcutaneous; Interleukin-2; Isotretinoin; Lomustine; Magnetic Resonance Imaging; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Procarbazine; Radioimmunotherapy; Radiosurgery; Recombinant Fusion Proteins; Retroviridae; Salvage Therapy; T-Lymphocytes, Cytotoxic; Tamoxifen; Temporal Lobe; Transfection; Tumor Cells, Cultured; Vincristine | 1995 |
Rapid resolution following chemotherapy of Broca's dysphasia due to recurrent anaplastic astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aphasia, Broca; Astrocytoma; Fatal Outcome; Follow-Up Studies; Frontal Lobe; Gyrus Cinguli; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neurologic Examination; Neuropsychological Tests; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1994 |
Brain tumor chemotherapy trials: slow start, but quickly gaining.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials as Topic; Humans; Lomustine; Oligodendroglioma; Procarbazine; Radiography; Vincristine | 1994 |
CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Prognosis; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine | 1993 |
Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Humans; Hydroxyurea; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Procarbazine; Survival Rate; Vincristine | 1994 |
Aplastic anemia induced by cyclohexylchloroethylnitrousurea.
Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood Cell Count; Brain Neoplasms; Combined Modality Therapy; Female; Humans; Lomustine; Procarbazine; Vincristine | 1994 |
Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Flow Cytometry; Humans; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Procarbazine; Proportional Hazards Models; Quality of Life; Survival Analysis; Treatment Outcome | 1993 |
[Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Lomustine; Male; Medulloblastoma; Methotrexate; Postoperative Care; Procarbazine; Prognosis; Radiotherapy Dosage; Vincristine | 1993 |
Low-grade oligodendroglioma responds to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Procarbazine; Vincristine | 1996 |
Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Topics: Antineoplastic Agents; Coloring Agents; Drug Screening Assays, Antitumor; Glioma; Humans; Lomustine; Procarbazine; Rhodamines; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine | 1996 |
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.
Topics: Adult; Astrocytoma; Brain Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prognosis; Time Factors; Vincristine | 1996 |
Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Drug Administration Schedule; Glioblastoma; Glioma; Humans; Hydroxyurea; Lomustine; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Radiography; Retreatment; Thioguanine | 1996 |
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine | 1996 |
Radiation and chemotherapy improve outcome in oligodendroglioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiotherapy Dosage; Vincristine | 1997 |
Diffuse involvement of the gastrointestinal tract with MALT lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Lomustine; Lymphoma, B-Cell, Marginal Zone; Male; Prednisone; Procarbazine; Vincristine | 1997 |
[Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oligodendroglioma; Pilot Projects; Procarbazine; Remission Induction; Vincristine | 1997 |
Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Vincristine | 1998 |
Bihemispheric malignant glioma: one size does not fit all.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Fatal Outcome; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1998 |
CCNU overdose during PCV chemotherapy for anaplastic astrocytoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Overdose; Female; Humans; Lomustine; Neutropenia; Procarbazine; Thrombocytopenia; Vincristine | 1998 |
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Oligodendroglioma; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Vincristine | 1998 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cause of Death; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Leukemia; Leukemia, Radiation-Induced; Lomustine; Male; Mechlorethamine; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Odds Ratio; Pelvis; Prednisone; Procarbazine; Radiotherapy; Risk; Splenectomy; Vincristine | 1998 |
A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
Topics: Administration, Oral; Adult; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Glioblastoma; Humans; Infusions, Intra-Arterial; Lomustine; Middle Aged; Procarbazine; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Procarbazine; Vincristine | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carmustine; Combined Modality Therapy; Female; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Procarbazine; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Vincristine | 1999 |
Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Glioma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Male; Procarbazine; Radiotherapy, Adjuvant; Vincristine | 1999 |
BUdR radiosensitization in anaplastic astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lomustine; Procarbazine; Radiation-Sensitizing Agents; Vincristine | 1999 |
Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors.
Topics: Adult; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Mixed Function Oxygenases; Phenytoin; Procarbazine; Vincristine | 1999 |
Spinal cord astrocytoma: response to PCV chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biopsy; Fatal Outcome; Humans; Lomustine; Magnetic Resonance Imaging; Male; Procarbazine; Spinal Cord Neoplasms; Treatment Failure; Vincristine | 2000 |
Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Drug Evaluation; Glioblastoma; Humans; Injections, Spinal; Lomustine; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Procarbazine; Radiotherapy, Adjuvant; Reoperation; Survival Analysis; Treatment Outcome; Vincristine | 1999 |
Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Child; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ependymoma; Female; Glioblastoma; Humans; Lomustine; Male; Medulloblastoma; Procarbazine; Tumor Cells, Cultured; Vincristine | 2000 |
PCV chemotherapy for recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 2001 |
Radiotherapy of esthesioneuroblastoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dacarbazine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Female; Follow-Up Studies; Humans; Lomustine; Male; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Vincristine | 2001 |
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Brain Diseases; Brain Neoplasms; Cachexia; Cerebral Hemorrhage; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Survival Analysis; Survival Rate; Thiotepa; Treatment Failure; Vincristine | 2000 |
PCV chemotherapy for recurrent glioblastoma multiforme.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Lomustine; Procarbazine; Prognosis; Treatment Outcome; Vincristine | 2001 |
Medical Research Council adjuvant trial in high-grade gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lomustine; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2001 |
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukopenia; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2002 |
Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Phenylbutyrates; Procarbazine; Treatment Outcome; Vincristine | 2002 |
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Corpus Callosum; Frontal Lobe; Humans; Lomustine; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Oligodendroglia; Parietal Lobe; Procarbazine; Remission Induction; Seizures; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease Progression; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Lomustine; Mutation; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Survival Analysis; Vincristine | 2003 |
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cytogenetic Analysis; Drug Resistance, Neoplasm; Humans; Lomustine; Neoplasms, Neuroepithelial; Oligodendroglioma; Predictive Value of Tests; Procarbazine; Radiography; Sequence Deletion; Treatment Outcome; Vincristine | 2003 |
[Use of modern technologies in the diagnosis and combined treatment of brain stem tumors].
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem; Cerebral Angiography; Chi-Square Distribution; Child; Child, Preschool; Combined Modality Therapy; Electroencephalography; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Ophthalmoscopy; Procarbazine; Prognosis; Radiotherapy Dosage; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2003 |
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Choline; Creatine; Energy Metabolism; Humans; Image Processing, Computer-Assisted; Lomustine; Magnetic Resonance Spectroscopy; Male; Neoplasm Recurrence, Local; Neurologic Examination; Procarbazine; Radiosurgery; Temporal Lobe; Tomography, Emission-Computed; Treatment Outcome; Vincristine | 2004 |
Long-term outcome of oligodendrogliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine | 2004 |
[Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults].
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Disease Progression; Drug Resistance; Epilepsy; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Procarbazine; Vincristine | 2004 |
Gliomatosis cerebri: better definition, better treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Astrocytoma; Brain; Brain Neoplasms; Cell Cycle Proteins; Dacarbazine; Disease Progression; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Neuroepithelial; Nerve Tissue Proteins; Procarbazine; Temozolomide; Vincristine | 2004 |
Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Combined Modality Therapy; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Recurrence; Vincristine | 2004 |
Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Polymerase Chain Reaction; Procarbazine; Retrospective Studies; Tumor Suppressor Protein p53; Vincristine | 2005 |
Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Oligodendroglioma; Positron-Emission Tomography; Procarbazine; Treatment Outcome; Vincristine | 2005 |
Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Cisplatin; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Vincristine | 2005 |
Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Follow-Up Studies; Humans; Lomustine; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Medulloblastoma; Procarbazine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2005 |
Toxic epidermal necrolysis after PCV combination chemotherapy for relapsed B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Lymphoma, B-Cell; Male; Middle Aged; Procarbazine; Stevens-Johnson Syndrome; Vincristine | 2006 |
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Dacarbazine; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Retrospective Studies; Survival Rate; Temozolomide; Vincristine | 2006 |
Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Case-Control Studies; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Genotype; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Prognosis; Risk Assessment; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2006 |
Anaplastic oligodendroglial tumors: a tale of two trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lomustine; Loss of Heterozygosity; Oligodendroglioma; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2006 |
Gliomatosis cerebri treatment in 11 elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Procarbazine; Survival Rate; Temozolomide | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease Progression; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genotype; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Prospective Studies; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Astrocytic tumors in children: treatment results from a single institution.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Lomustine; Male; Neurosurgical Procedures; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
[Long-term outcome in patients with symptomatic low-grade oligodendrogliomatous tumors treated by cytotoxic agents].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Follow-Up Studies; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiography; Treatment Outcome; Vincristine | 2006 |
Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous | 2008 |
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Carboplatin; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Hepatocytes; Humans; Lomustine; Male; Membrane Glycoproteins; Middle Aged; Procarbazine; Recombinant Fusion Proteins; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine | 2008 |
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Radiotherapy; Radiotherapy Dosage; Temozolomide; Vincristine | 2008 |
Procarbazine and CCNU as initial treatment in gliomatosis cerebri.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease-Free Survival; Female; Humans; Lomustine; Male; Middle Aged; Neoplasms, Neuroepithelial; Pilot Projects; Procarbazine; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
Topics: Administration, Oral; Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV-1; Humans; Kenya; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome; Uganda; Virus Replication; Young Adult | 2009 |
Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 2009 |
Natural history and outcome of optic pathway gliomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Intellectual Disability; Lomustine; Male; Neurofibromatosis 1; Optic Nerve Glioma; Procarbazine; Retrospective Studies; Survival Analysis; Thioguanine; Treatment Outcome; Vinblastine; Vincristine; Vision Disorders | 2009 |
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Regulation, Neoplastic; Glioma; Humans; Lomustine; Procarbazine; Promoter Regions, Genetic; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Research Design; Survival Analysis; Temozolomide; Time Factors; Treatment Failure; Tumor Suppressor Proteins; Vincristine | 2009 |
Bevacizumab is active as a single agent against recurrent malignant gliomas.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Doxorubicin; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vincristine | 2010 |
Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Procarbazine; Retrospective Studies; Vincristine | 2010 |
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Follow-Up Studies; Humans; International Agencies; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiotherapy; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vincristine; Young Adult | 2011 |
Prophylactic intrathecal chemotherapy in primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Humans; Injections, Spinal; Karnofsky Performance Status; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neuroprotective Agents; Procarbazine; Retrospective Studies; Young Adult | 2012 |
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Drug Resistance, Neoplasm; Lomustine; Lymphoma; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Vincristine | 2011 |
Chemotherapy and radiotherapy combination extends survival for patients with oligodendroglial tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Proliferation; Chemoradiotherapy; Disease-Free Survival; Humans; Lomustine; Oligodendroglioma; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2012 |
Prolonged survival associated with the use of intraoperative carmustine (Gliadel) in a paediatric patient with recurrent grade III astrocytoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Carmustine; Combined Modality Therapy; Drug Implants; Female; Humans; Lomustine; Neoplasm Recurrence, Local; Procarbazine; Time Factors; Treatment Outcome | 2013 |
PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials, Phase III as Topic; Humans; Lomustine; Oligodendroglioma; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2013 |
How to use molecular markers when caring for a patient with brain cancer: 1P/19Q as a predictive and prognostic marker in the neuro-oncology clinic.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease-Free Survival; Humans; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy; Translocation, Genetic; Vincristine | 2013 |
Anaplastic oligodendroglioma: a new treatment paradigm and current controversies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Female; Gene Deletion; Humans; Lomustine; Male; Oligodendroglioma; Patient Selection; Procarbazine; Quality of Life; Radiotherapy, High-Energy; Survival Analysis; Vincristine | 2013 |
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cluster Analysis; CpG Islands; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Gene Expression Profiling; Humans; Lomustine; Male; Oligodendroglioma; Phenotype; Procarbazine; Prognosis; Promoter Regions, Genetic; Treatment Outcome; Tumor Suppressor Proteins; Vincristine | 2013 |
Introduction of a new vaccine in EPI; what we can achieve from a programme in failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Immunization Programs; Immunization Schedule; Lomustine; Pneumococcal Infections; Pneumococcal Vaccines; Procarbazine; Vaccination; Vincristine | 2014 |
Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden; Vincristine | 2015 |
Comparative efficacy of bevacizumab and PCV chemotherapy in recurrent glioblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Glioblastoma; Humans; Lomustine; Procarbazine; Retrospective Studies; Vincristine | 2015 |
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Lomustine; Neoplasm Grading; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine | 2015 |
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Lomustine; Neoplasm Grading; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine | 2015 |
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Chemotherapy, Adjuvant; Cohort Studies; Female; Glioblastoma; Humans; Irinotecan; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Portugal; Prevalence; Procarbazine; Retrospective Studies; Risk Assessment; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 2015 |
PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2015 |
High-grade glioma in children and adolescents: a single-center experience.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Karnofsky Performance Status; Lomustine; Male; Neurosurgical Procedures; Procarbazine; Prognosis; Proportional Hazards Models; Radiotherapy; Retrospective Studies; Survival Rate; Temozolomide; Vincristine | 2016 |
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine | 2015 |
Increasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Computational Biology; Computer Simulation; Drug Administration Schedule; Glioma; Humans; Kaplan-Meier Estimate; Lomustine; Mathematical Concepts; Models, Biological; Monte Carlo Method; Procarbazine; Vincristine | 2015 |
Chemotherapy for intracranial ependymoma in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Ependymoma; Epirubicin; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Procarbazine; Temozolomide; Treatment Outcome; Vincristine | 2016 |
LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Lymphoma, T-Cell; Male; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2018 |
Cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Cost-Benefit Analysis; Decision Trees; Disease Progression; Glioma; Humans; Lomustine; Neoplasm Grading; Procarbazine; Quality-Adjusted Life Years; Survival Rate; Treatment Outcome; Vincristine | 2017 |
Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisolone; Procarbazine; Recurrence; Treatment Outcome | 2018 |
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Glioma; Humans; Lomustine; Neoplasm Grading; Procarbazine; Promoter Regions, Genetic; Quality of Life; Randomized Controlled Trials as Topic; Temozolomide; Tumor Suppressor Proteins; Vincristine | 2018 |
Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dog Diseases; Dogs; Female; Lomustine; Lymphoma, T-Cell; Male; Prednisolone; Procarbazine; Survival Analysis; Vincristine | 2018 |
Radiotherapy plus temozolomide or PCV in patients with anaplastic oligodendroglioma 1p19q codeleted.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Female; Gene Deletion; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Retrospective Studies; Temozolomide; Vincristine; Young Adult | 2018 |
Salvage chemotherapy after failure of targeted therapy in a child with BRAF V600E low-grade glioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Glioma; Humans; Lomustine; Male; Molecular Targeted Therapy; Mutation; Procarbazine; Prognosis; Proto-Oncogene Proteins B-raf; Salvage Therapy; Thioguanine; Vincristine | 2021 |
A comparative study of the effectiveness and safety of combined procarbazine, lomustine, and vincristine as a therapeutic method for recurrent high-grade glioma: A protocol for systematic review and meta-analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioma; Humans; Lomustine; Meta-Analysis as Topic; Neoplasm Grading; Neoplasm Recurrence, Local; Procarbazine; Systematic Reviews as Topic; Vincristine; Young Adult | 2020 |
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Humans; Lomustine; Procarbazine; Retrospective Studies; Temozolomide; Vincristine | 2021 |
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Glioma; Humans; Incidence; Ireland; Lomustine; Male; Neoplasm Grading; Procarbazine; Retrospective Studies; Time Factors; Vincristine | 2021 |
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Neoplasm Staging; Oligodendroglioma; Procarbazine; Temozolomide; Vincristine; World Health Organization | 2021 |
Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Hypercalcemia; Lomustine; Lymphoma; Lymphoma, T-Cell; Prednisolone; Procarbazine; Prognosis; Retrospective Studies; T-Lymphocytes; Vincristine | 2022 |
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lomustine; Lymphoma; Methotrexate; Middle Aged; Procarbazine; Receptors, Thrombopoietin; Rituximab | 2022 |
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.
Topics: Adult; Brain Neoplasms; DNA Methylation; Humans; Isocitrate Dehydrogenase; Lomustine; Methyltransferases; Oligodendroglioma; Procarbazine; Prospective Studies; Retrospective Studies; Temozolomide; Vincristine; World Health Organization | 2022 |
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Retrospective Studies; Vincristine | 2023 |